Edmonds, N. L. L., Gradecki, S. E., Katyal, P., Lynch, K. T., Stowman, A. M., Gru, A. A., . . . Mauldin, I. S. S. (2023). Tertiary lymphoid structures in desmoplastic melanoma have increased lymphocyte density, lymphocyte proliferation, and immune cross talk with tumor when compared to non-desmoplastic melanomas. ONCOIMMUNOLOGY, 12(1). doi:10.1080/2162402X.2022.2164476

Lindsay, R. S. S., Melssen, M. M. M., Stasiak, K., Annis, J. L. L., Woods, A. N. N., Rodriguez, A. B. B., . . . Engelhard, V. H. H. (2022). NK cells reduce anergic T cell development in early-stage tumors by promoting myeloid cell maturation. FRONTIERS IN ONCOLOGY, 12. doi:10.3389/fonc.2022.1058894

Rodriguez, A. B., Parriott, G., & Engelhard, V. H. (2022). Tumor necrosis factor receptor regulation of peripheral node addressin biosynthetic components in tumor endothelial cells. FRONTIERS IN IMMUNOLOGY, 13. doi:10.3389/fimmu.2022.1009306

Jaiswal, A., Verma, A., Dannenfelser, R., Melssen, M., Tirosh, I., Izar, B., . . . Anandasabapathy, N. (2022). An activation to memory differentiation trajectory of tumor-infiltrating lymphocytes informs metastatic melanoma outcomes. CANCER CELL, 40(5), 524-+. doi:10.1016/j.ccell.2022.04.005

Lynch, K. T., Young, S. J., Meneveau, M. O., Wages, N. A., Engelhard, V. H., Slingluff, C. L. J., & Mauldin, I. S. (2021). Heterogeneity in tertiary lymphoid structure B-cells correlates with patient survival in metastatic melanoma. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 9(6). doi:10.1136/jitc-2020-002273

Kwak, M., Erdag, G., Leick, K. M., Bekiranov, S., Engelhard, V. H., & Slingluff, C. L. (2021). Associations of immune cell homing gene signatures and infiltrates of lymphocyte subsets in human melanomas: discordance with CD163⁺ myeloid cell infiltrates. JOURNAL OF TRANSLATIONAL MEDICINE, 19(1). doi:10.1186/s12967-021-03044-5

Lulu, A. M., Cummings, K. L., Jeffery, E. D., Myers, P. T., Underwood, D., Lacy, R. M., . . . Engelhard, V. H. (2021). Characteristics of Immune Memory and Effector Activity to Cancer-Expressed MHC Class I Phosphopeptides Differ in Healthy Donors and Ovarian Cancer Patients. CANCER IMMUNOLOGY RESEARCH, 9(11), 1327-1341. doi:10.1158/2326-6066.CIR-21-0111

Rodriguez, A. B., Peske, J. D., Woods, A. N., Leick, K. M., Mauldin, I. S., Meneveau, M. O., . . . Engelhard, V. H. (2021). Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts. CELL REPORTS, 36(3). doi:10.1016/j.celrep.2021.109422

Pinczewski, J., Obeng, R. C., Slingluff, C. L. J., & Engelhard, V. H. (2021). Phospho-β-catenin expression in primary and metastatic melanomas and in tumor-free visceral tissues, and associations with expression of PD-L1 and PD-L2. PATHOLOGY RESEARCH AND PRACTICE, 224. doi:10.1016/j.prp.2021.153527

Melssen, M. M., Lindsay, R. S., Stasiak, K., Rodriguez, A. B., Briegel, A. M., Cyranowski, S., . . . Engelhard, V. H. (2021). Differential Expression of CD49a and CD49b Determines Localization and Function of Tumor-Infiltrating CD8⁺ T Cells. CANCER IMMUNOLOGY RESEARCH, 9(5), 583-597. doi:10.1158/2326-6066.CIR-20-0427

Rodriguez, A. B., & Engelhard, V. H. (2020). Insights into Tumor-Associated Tertiary Lymphoid Structures: Novel Targets for Antitumor Immunity and Cancer Immunotherapy. CANCER IMMUNOLOGY RESEARCH, 8(11), 1338-1345. doi:10.1158/2326-6066.CIR-20-0432

Engelhard, V. H., Obeng, R. C., Cummings, K. L., Petroni, G. R., Ambakhutwala, A. L., Chianese-Bullock, K. A., . . . Slingluff, C. L. J. (2020). MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanoma. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 8(1). doi:10.1136/jitc-2019-000262

Pinczewski, J., Obeng, R., Slingluff, C., & Engelhard, V. (2020). Phospho-β-catenin expression in primary and metastatic melanomas and in tumor-free visceral tissues. doi:10.1101/2020.09.13.295410

Lulu, A. M., Cummings, K. L., & Engelhard, V. H. (2020). Evidence of ongoing immune surveillance to cancer-associated phosphopeptides in healthy individuals. In JOURNAL OF IMMUNOLOGY Vol. 204.

Stasiak, K., Lindsay, R., & Engelhard, V. H. (2020). Low immunogenicity of intracranial tumors limits immune response to brain malignancies. In JOURNAL OF IMMUNOLOGY Vol. 204.

Curley, C. T., Stevens, A. D., Mathew, A. S., Stasiak, K., Garrison, W. J., Miller, G. W., . . . Price, R. J. (2020). Immunomodulation of intracranial melanoma in response to blood-tumor barrier opening with focused ultrasound. THERANOSTICS, 10(19), 8821-8833. doi:10.7150/thno.47983

Lulu, A. M., Cummings, K. L., & Engelhard, V. H. (2020). Pre-existing immune memory to cancer-associated phosphopeptides in healthy donors.. In CANCER IMMUNOLOGY RESEARCH Vol. 8 (pp. 114-115).

Dellacecca, E. R., Cosgrove, C., Mukhatayev, Z., Akhtar, S., Engelhard, V. H., Rademaker, A. W., . . . Le Poole, I. C. (2020). Antibiotics Drive Microbial Imbalance and Vitiligo Development in Mice. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 140(3), 676-+. doi:10.1016/j.jid.2019.08.435

Leick, K. M., Rodriguez, A. B., Melssen, M. M., Benamar, M., Lindsay, R. S., Eki, R., . . . Slingluff, C. L. J. (2019). The Barrier Molecules Junction Plakoglobin, Filaggrin, and Dystonin Play Roles in Melanoma Growth and Angiogenesis. ANNALS OF SURGERY, 270(4), 712-722. doi:10.1097/SLA.0000000000003522

Leick, K. M., Pinczewski, J., Mauldin, I. S., Young, S. J., Deacon, D. H., Woods, A. N., . . . Slingluff, C. L. J. (2019). Patterns of immune-cell infiltration in murine models of melanoma: roles of antigen and tissue site in creating inflamed tumors. In CANCER IMMUNOLOGY IMMUNOTHERAPY Vol. 68 (pp. 1121-1132). doi:10.1007/s00262-019-02345-5

Dellacecca, E., Cosgrove, C., Mukhatayev, Z., Akhtar, S., Engelhard, V. H., Rademaker, A. W., . . . Le Poole, I. C. (2019). 521 Ampicillin drives gut dysbiosis and progressive depigmentation in a mouse model of vitiligo.. In Journal of Investigative Dermatology Vol. 139 (pp. S89). Elsevier BV. doi:10.1016/j.jid.2019.03.597

Cosgrove, P., Dellacecca, E. R., Akhtar, S., Engelhard, V. H., Knight, K. L., & Le Poole, I. C. (2019). Antibiotics modify outcomes in vitiligo. In JOURNAL OF INVESTIGATIVE DERMATOLOGY Vol. 139 (pp. S306). doi:10.1016/j.jid.2019.07.449

Santambrogio, L., Berendam, S. J., & Engelhard, V. H. (2019). The Antigen Processing and Presentation Machinery in Lymphatic Endothelial Cells. FRONTIERS IN IMMUNOLOGY, 10. doi:10.3389/fimmu.2019.01033

Dellacecca, E., Cosgrove, C., Mukhatayev, Z., Akhtar, S., Engelhard, V. H., Rademaker, A. W., . . . Le Poole, I. C. (2019). Ampicillin drives gut dysbiosis and progressive depigmentation in a mouse model of vitiligo. In JOURNAL OF INVESTIGATIVE DERMATOLOGY Vol. 139 (pp. S89).

Berendam, S. J., Koeppel, A. F., Godfrey, N. R., Rouhani, S. J., Woods, A. N., Rodriguez, A. B., . . . Engelhard, V. H. (2019). Comparative Transcriptomic Analysis Identifies a Range of Immunologically Related Functional Elaborations of Lymph Node Associated Lymphatic and Blood Endothelial Cells. FRONTIERS IN IMMUNOLOGY, 10. doi:10.3389/fimmu.2019.00816

Engelhard, V. H., Rodriguez, A. B., Mauldin, I. S., Woods, A. N., Peske, J. D., & Slingluff, C. L. J. (2018). Immune Cell Infiltration and Tertiary Lymphoid Structures as Determinants of Antitumor Immunity. JOURNAL OF IMMUNOLOGY, 200(2), 432-442. doi:10.4049/jimmunol.1701269

Rodriguez, A. B., Peske, J. D., Woods, A. N., Melssen, M. M., Cyranowski, S., Parriott, G. R., & Engelhard, V. H. (2018). Cellular and molecular mechanisms regulating the development of tertiary lymphoid structures in tumor. In JOURNAL OF IMMUNOLOGY Vol. 200.

Melssen, M. M., Olson, W., Wages, N. A., Capaldo, B. J., Mauldin, I. S., Mahmutovic, A., . . . Slingluff, C. L. J. (2018). Formation and phenotypic characterization of CD49a, CD49b and CD103 expressing CD8 T cell populations in human metastatic melanoma. ONCOIMMUNOLOGY, 7(10). doi:10.1080/2162402X.2018.1490855

Rodriguez, A. B., Peske, J. D., & Engelhard, V. H. (2018). Identification and Characterization of Tertiary Lymphoid Structures in Murine Melanoma. TERTIARY LYMPHOID STRUCTURES: METHODS AND PROTOCOLS, 1845, 241-257. doi:10.1007/978-1-4939-8709-2_14

Hailemichael, Y., Woods, A., Fu, T., He, Q., Nielsen, M. C., Hasan, F., . . . Overwijk, W. W. (2018). Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy. JOURNAL OF CLINICAL INVESTIGATION, 128(4), 1338-1354. doi:10.1172/JCI93303

Woods, A. N., Wilson, A. L., Srivinisan, N., Zeng, J., Dutta, A. B., Peske, J. D., . . . Engelhard, V. H. (2017). Differential Expression of Homing Receptor Ligands on Tumor-Associated Vasculature that Control CD8 Effector T-cell Entry. CANCER IMMUNOLOGY RESEARCH, 5(12), 1062-1073. doi:10.1158/2326-6066.CIR-17-0190

Mohammed, F., Stones, D. H., Zarling, A. L., Willcox, C. R., Shabanowitz, J., Cummings, K. L., . . . Willcox, B. E. (2017). The antigenic identity of human class I MHC phosphopeptides is critically dependent upon phosphorylation status.. Oncotarget, 8(33), 54160-54172. doi:10.18632/oncotarget.16952

Uduman, M., Khattar, M., Joshi, B., Tanne, A., Morin, B., Karapetyan, A., . . . Castle, J. (2017). Abstract 4609: Agenusâ next generation cancer vaccine platforms. In Cancer Research Vol. 77 (pp. 4609). American Association for Cancer Research (AACR). doi:10.1158/1538-7445.am2017-4609

Devi, K., Melssen, M., Tirosh, I., Izar, B., Olson, W., Engelhard, V., . . . Anandasabapathy, N. (2017). Human melanoma TILs share phenotypic and transcriptional properties with tissue resident memory T cells. In JOURNAL OF INVESTIGATIVE DERMATOLOGY Vol. 137 (pp. S11). doi:10.1016/j.jid.2017.02.075

Akhtar, S., Dellacecca, E., Engelhard, V., Knight, K., & Le Poole, C. (2017). Dysbiosis of gut microbiota by ampicillin exacerbates vitiligo. In JOURNAL OF INVESTIGATIVE DERMATOLOGY Vol. 137 (pp. S142). doi:10.1016/j.jid.2017.02.853

Mohammed, F., Stones, D. H., Zarling, A. L., Willcox, C. R., Shabanowitz, J., Cummings, K. L., . . . Willcox, B. E. (2017). The antigenic identity of human class I MHC phosphopeptides is critically dependent upon phosphorylation status. ONCOTARGET, 8(33), 54160-54172. doi:10.18632/oncotarget.16952

Hailemichael, Y., Fu, T., Woods, A., Roszik, J., Schluns, K. S., Engelhard, V. H., . . . Overwijk, W. W. (2016). Abstract A031: Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy. In Cancer Immunology Research Vol. 4 (pp. A031). American Association for Cancer Research (AACR). doi:10.1158/2326-6066.imm2016-a031

Malaker, S. A., Ferracane, M. J., Depontieu, F. R., Zarling, A. L., Shabanowitz, J., Bai, D. L., . . . Hunt, D. F. (2017). Identification and Characterization of Complex Glycosylated Peptides Presented by the MHC Class II Processing Pathway in Melanoma. JOURNAL OF PROTEOME RESEARCH, 16(1), 228-237. doi:10.1021/acs.jproteome.6b00496

Hailemichael, Y., Fu, T., Woods, A., Schluns, K., Engelhard, V. H., Sharma, P., & Overwijk, W. W. (2016). Effect of cancer vaccine formulation on synergy with anti-CTLA-4 and anti-PD-L1 checkpoint blockade therapy of cancer. In JOURNAL OF CLINICAL ONCOLOGY Vol. 34. doi:10.1200/JCO.2016.34.15_suppl.3094

Ager, C., Reilley, M., Nicholas, C., Bartkowiak, T., Jaiswal, A., Curran, M., . . . Kortylewski, M. (2016). 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016.. In Journal for immunotherapy of cancer Vol. 4 (pp. 107-221). doi:10.1186/s40425-016-0173-6

Melssen, M. M., Rodriguez, A. B., Slingluff, C. L., & Engelhard, V. H. (2016). CD49a and CD103 expression on tumor infiltrating lymphocytes in B16-OVA tumors depends on location and is correlated with a naive phenotype. In JOURNAL OF IMMUNOLOGY Vol. 196.

Wilson, A. L., Woods, A. N., & Engelhard, V. H. (2016). Immunosuppression limits CD8⁺ T cell entry. In JOURNAL OF IMMUNOLOGY Vol. 196.

Woods, A. N., Wilson, A. L., Srivinasan, N., & Engelhard, V. H. (2016). Effector CD8 T cells use different homing receptor/ligand interactions to enter subcutaneous and intraperitoneal B16 melanoma tumors. In JOURNAL OF IMMUNOLOGY Vol. 196.

Rodriguez, A. B., Peske, J. D., Woods, A. N., & Engelhard, V. H. (2016). Regulation of peripheral node addressin in tumor-associated CD31⁺ vascular endothelial cells.. In JOURNAL OF IMMUNOLOGY Vol. 196.

Engelhard, V. H., Peske, D., Woods, A., Srinivasan, N., Brinkman, C., & Ferguson, A. (2015). Abstract IA23: T cell trafficking in lymphoid and non-lymphoid tissues. In Cancer Immunology Research Vol. 3 (pp. IA23). American Association for Cancer Research (AACR). doi:10.1158/2326-6074.tumimm14-ia23

Peske, J. D., Thompson, E. D., Gemta, L., Baylis, R. A., Fu, Y. -X., & Engelhard, V. H. (2015). Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity. NATURE COMMUNICATIONS, 6. doi:10.1038/ncomms8114

Woods, A., Srivinasan, N., & Engelhard, V. (2015). Effector T_CD8 use different homing receptor/ligand interactions to enter subcutaneous and intraperitoneal B16 melanoma tumors. In JOURNAL OF IMMUNOLOGY Vol. 194.

Peske, J., Thompson, E., Gemta, L., Baylis, R., Fu, Y., & Engelhard, V. (2015). Effector lymphocytes induce lymph node-like vasculature in tumors, which enables naive T cell infiltration and enhanced anti-tumor immunity. In JOURNAL OF IMMUNOLOGY Vol. 194.

Cohen, J. N., Rouhani, S. J., Tewalt, E. F., Buonomo, E. L., Bruce, A. N., Riccardi, P., . . . Engelhard, V. H. (2015). Induction of peripheral tolerance in CD8 and CD4 T cells by lymphatic endothelial cells. In MOLECULAR IMMUNOLOGY Vol. 68 (pp. 154).

Peske, J. D., Woods, A. B., & Engelhard, V. H. (2015). Control of CD8 T-Cell Infiltration into Tumors by Vasculature and Microenvironment. IMMUNOTHERAPY OF CANCER, 128, 263-307. doi:10.1016/bs.acr.2015.05.001

Rouhani, S. J., Eccles, J. D., Riccardi, P., Peske, J. D., Tewalt, E. F., Cohen, J. N., . . . Engelhard, V. H. (2015). Roles of lymphatic endothelial cells expressing peripheral tissue antigens in CD4 T-cell tolerance induction. NATURE COMMUNICATIONS, 6. doi:10.1038/ncomms7771

Zarling, A. L., Obeng, R. C., Desch, A. N., Pinczewski, J., Cummings, K. L., Deacon, D. H., . . . Engelhard, V. H. (2014). MHC-restricted phosphopeptides from insulin receptor substrate-2 and CDC25b offer broad-based immunotherapeutic agents for cancer.. Cancer research, 74(23), 6784-6795. doi:10.1158/0008-5472.can-14-0043

Eby, J. M., Kang, H. -K., Klarquist, J., Chatterjee, S., Mosenson, J. A., Nishimura, M. I., . . . Le Poole, I. C. (2014). Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation.. Pigment cell & melanoma research, 27(6), 1075-1085. doi:10.1111/pcmr.12284

Brinkman, C. C., Rouhani, S. J., Srinivasan, N., & Engelhard, V. H. (2014). Correction: Peripheral Tissue Homing Receptors Enable T Cell Entry into Lymph Nodes and Affect the Anatomical Distribution of Memory Cells. The Journal of Immunology, 192(8), 3992-3995. doi:10.4049/jimmunol.1490008

Rouhani, S. J., Eccles, J. D., Tewalt, E. F., & Engelhard, V. H. (2014). Regulation of T-cell Tolerance by Lymphatic Endothelial Cells.. Journal of clinical & cellular immunology, 5, 1000242. doi:10.4172/2155-9899.1000242

Eby, J. M., Kang, H. -K., Klarquist, J., Chatterjee, S., Mosenson, J. A., Nishimura, M. I., . . . Le Poole, I. C. (2014). Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation. PIGMENT CELL & MELANOMA RESEARCH, 27(6), 1075-1085. doi:10.1111/pcmr.12284

Zarling, A. L., Obeng, R. C., Desch, A. N., Pinczewski, J., Cummings, K. L., Deacon, D. H., . . . Engelhard, V. H. (2014). MHC-Restricted Phosphopeptides from Insulin Receptor Substrate-2 and CDC25b Offer Broad-Based Immunotherapeutic Agents for Cancer. CANCER RESEARCH, 74(23), 6784-6795. doi:10.1158/0008-5472.CAN-14-0043

Cohen, J. N., Tewalt, E. F., Rouhani, S. J., Buonomo, E. L., Bruce, A. N., Xu, X., . . . Engelhard, V. H. (2014). Tolerogenic Properties of Lymphatic Endothelial Cells Are Controlled by the Lymph Node Microenvironment. PLOS ONE, 9(2). doi:10.1371/journal.pone.0087740

Brinkman, C. C., Rouhani, S. J., Srinivasan, N., & Engelhard, V. H. (2013). Correction: Peripheral Tissue Homing Receptors Enable T Cell Entry into Lymph Nodes and Affect the Anatomical Distribution of Memory Cells. The Journal of Immunology, 191(12), 6292. doi:10.4049/jimmunol.1390066

Cobbold, M., De La Pena, H., Norris, A., Polefrone, J. M., Qian, J., English, A. M., . . . Engelhard, V. H. (2013). MHC Class I-Associated Phosphopeptides Are the Targets of Memory-like Immunity in Leukemia. SCIENCE TRANSLATIONAL MEDICINE, 5(203). doi:10.1126/scitranslmed.3006061

Rival, C., Wheeler, K., Jeffrey, S., Qiao, H., Luu, B., Tewalt, E. F., . . . Tung, K. (2013). Regulatory T cells and vasectomy. JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 100(1), 66-75. doi:10.1016/j.jri.2013.08.004

Engels, B., Engelhard, V. H., Sidney, J., Sette, A., Binder, D. C., Liu, R. B., . . . Schreiber, H. (2013). Relapse or Eradication of Cancer Is Predicted by Peptide-Major Histocompatibility Complex Affinity. CANCER CELL, 23(4), 516-526. doi:10.1016/j.ccr.2013.03.018

Rouhani, S., Tewalt, E., Davis, H., Chen, L., & Engelhard, V. (2013). Lymphatic endothelial cells induce anergy of β-galactosidase specific CD4 T cells by providing antigen to CD11c cells. In JOURNAL OF IMMUNOLOGY Vol. 190.

Brinkman, C. C., Peske, J. D., & Engelhard, V. H. (2013). Peripheral tissue homing receptor control of naive, effector, and memory CD8 T cell localization in lymphoid and non-lymphoid tissues. FRONTIERS IN IMMUNOLOGY, 4. doi:10.3389/fimmu.2013.00241

Brinkman, C. C., Rouhani, S. J., Srinivasan, N., & Engelhard, V. H. (2013). Peripheral Tissue Homing Receptors Enable T Cell Entry into Lymph Nodes and Affect the Anatomical Distribution of Memory Cells. JOURNAL OF IMMUNOLOGY, 191(5), 2412-2425. doi:10.4049/jimmunol.1300651

Zarling, A. L., Obeng, R. C., Cummings, K. L., Desch, A. N., English, A. M., Cottine, J. M., . . . Engelhard, V. H. (2012). MHC-restricted phosphopeptides as broad-based immunotherapeutic targets for cancer. In CANCER RESEARCH Vol. 72. doi:10.1158/1538-7445.AM2012-1584

De La Pena, H., Turner, J. E., Butler, T., Buka, R., Morton, L., Penny, S., . . . Cobbold, M. (2012). Leukemia-specific immunity in healthy individuals and patients post-transplant targets phosphorylated tumor antigens. In CANCER RESEARCH Vol. 72. doi:10.1158/1538-7445.AM2012-512

Cohen, J., Fu, Y. -X., & Engelhard, V. (2012). Tolerogenic properties of lymphatic endothelial cells are controlled by the lymph node microenvironment. In JOURNAL OF IMMUNOLOGY Vol. 188.

Tewalt, E. F., Cohen, J. N., Rouhani, S. J., & Engelhard, V. H. (2012). Lymphatic endothelial cells - key players in regulation of tolerance and immunity. FRONTIERS IN IMMUNOLOGY, 3. doi:10.3389/fimmu.2012.00305

Tewalt, E., Cohen, J., Rouhani, S., Guidi, C., Qiao, H., Fahl, S., . . . Engelhard, V. (2012). Peripheral tolerance induction by PD-L1+lymphatic endothelial cell is due to deficient costimulation that leads to rapid, high-level expression of PD-1 on CD8 T cells. In JOURNAL OF IMMUNOLOGY Vol. 188.

Tewalt, E., Cohen, J., Rouhani, S., Guidi, C., Qiao, H., Fahl, S., . . . Engelhard, V. (2012). Peripheral tolerance induction by PD-L1+lymphatic endothelial cell is due to deficient costimulation that leads to rapid, high-level expression of PD-1 on CD8 T cells. In JOURNAL OF IMMUNOLOGY Vol. 188.

Tewalt, E. F., Cohen, J. N., Rouhani, S. J., Guidi, C. J., Qiao, H., Fahl, S. P., . . . Engelhard, V. H. (2012). Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells. BLOOD, 120(24), 4772-4782. doi:10.1182/blood-2012-04-427013

Obeng, R., Zarling, A., & Engelhard, V. (2011). A modified form of a tumor-associated phosphorylated peptide derived from BCAR3 generates CD8 T cells that are highly crossreactive to the natural phosphopeptide and capable of recognizing tumor cells. In JOURNAL OF IMMUNOLOGY Vol. 186.

Li, Y., Depontieu, F. R., Sidney, J., Salay, T. M., Engelhard, V. H., Hunt, D. F., . . . Mariuzza, R. A. (2010). Structural Basis for the Presentation of Tumor-Associated MHC Class II-Restricted Phosphopeptides to CD4⁺ T Cells. JOURNAL OF MOLECULAR BIOLOGY, 399(4), 596-603. doi:10.1016/j.jmb.2010.04.037

Obeng, R. C., Le Poole, I. C., Hunt, D. F., & Engelhard, V. H. (2010). Abstract B14: A phosphorylated β-catenin peptide that is presented by HLA-A2 MHC molecules generates strong phosphospecific T cell responses against melanoma. In Clinical Cancer Research Vol. 16 (pp. B14). American Association for Cancer Research (AACR). doi:10.1158/1078-0432.tcme10-b14

Obeng, R., Le Poole, I., Hunt, D., & Engelhard, V. (2010). A phosphorylated β-catenin peptide that is presented by HLA-A2 generates strong phosphospecific T cell responses against melanoma. In JOURNAL OF IMMUNOLOGY Vol. 184.

Mohammed, F., Stones, D. H., Zarling, A. L., Hunt, D. F., Engelhard, V. H., Cobbold, M., & Willcox, B. E. (2010). Phosphorylation induces radical conformational changes in naturally processed class I MHC phosphopeptide antigens. In IMMUNOLOGY Vol. 131 (pp. 147).

Gregg, R. K., Nichols, L., Chen, Y., Lu, B., & Engelhard, V. H. (2010). Mechanisms of Spatial and Temporal Development of Autoimmune Vitiligo in Tyrosinase-Specific TCR Transgenic Mice. JOURNAL OF IMMUNOLOGY, 184(4), 1909-1917. doi:10.4049/jimmunol.0902778

Ferguson, A. R., & Engelhard, V. H. (2010). CD8 T Cells Activated in Distinct Lymphoid Organs Differentially Express Adhesion Proteins and Coexpress Multiple Chemokine Receptors. JOURNAL OF IMMUNOLOGY, 184(8), 4079-4086. doi:10.4049/jimmunol.0901903

Thompson, E. D., Enriquez, H. L., Fu, Y. -X., & Engelhard, V. H. (2010). Tumor masses support naive T cell infiltration, activation, and differentiation into effectors. JOURNAL OF EXPERIMENTAL MEDICINE, 207(8), 1791-1804. doi:10.1084/jem.20092454

Cohen, J. N., Guidi, C. J., Tewalt, E. F., Qiao, H., Rouhani, S. J., Ruddell, A., . . . Engelhard, V. H. (2010). Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation. JOURNAL OF EXPERIMENTAL MEDICINE, 207(4), 681-688. doi:10.1084/jem.20092465

De La Pena, H., Butler, T., Huang, H. -W., Jakhira, T., Joseph, C. -Y., Penny, S., . . . Cobbold, M. (2010). Immunologically Targeting the Leukaemia Phosphoproteome. In BLOOD Vol. 116 (pp. 446-447).

Hulse, K. E., Reefer, A. J., Engelhard, V. H., Patrie, J. T., Ziegler, S. F., Chapman, M. D., & Woodfolk, J. A. (2010). Targeting allergen to FcγRI reveals a novel T_H2 regulatory pathway linked to thymic stromal lymphopoietin receptor. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 125(1), 247-256. doi:10.1016/j.jaci.2009.10.027

Depontieu, F., Qian, J., Zarling, A., McMiller, T., Shabanowitz, J., Hunt, D., . . . Topalian, S. (2009). Tumor-associated MHC II-restricted phosphopeptides: Identification of new immunological targets. In CANCER RESEARCH Vol. 69. Retrieved from http://gateway.webofknowledge.com/

Nicholls, S., Piper, K. P., Mohammed, F., Dafforn, T. R., Tenzer, S., Salim, M., . . . Willcox, B. E. (2009). Secondary anchor polymorphism in the HA-1 minor histocompatibility antigen critically affects MHC stability and TCR recognition. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 106(10), 3889-3894. doi:10.1073/pnas.0900411106

Vincent, I. S., Linden, J. M., & Engelhard, V. H. (2009). Deletion of adenosine A_2A receptors on CD8 T cells enhances their accumulation in tumors and tumor-draining lymph nodes, as well as their ability to control tumor outgrowth. In JOURNAL OF IMMUNOLOGY Vol. 182.

Depontieu, F., Qian, J., Zarling, A., McMiller, T., Shabanowitz, J., Hunt, D., . . . Topalian, S. (2009). Tumor-associated MHC II-restricted phosphopeptides: Identification of new immunological targets. In CANCER RESEARCH Vol. 69.

Depontieu, F. R., Qian, J., Zarling, A. L., McMiller, T. L., Salay, T. M., Norris, A., . . . Topalian, S. L. (2009). Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 106(29), 12073-12078. doi:10.1073/pnas.0903852106

Ostankovitch, M., Altrich-VanLith, M., Robila, V., & Engelhard, V. H. (2009). N-Glycosylation Enhances Presentation of a MHC Class I-Restricted Epitope from Tyrosinase. JOURNAL OF IMMUNOLOGY, 182(8), 4830-4835. doi:10.4049/jimmunol.0802902

Hulse, K. E., Reefer, A. J., Satinover, S. M., Chapman, M. D., Engelhard, V. H., & Woodfolk, J. A. (2009). Thymic Stromal Lymphopoietin Potentiates the Immunomodulatory Effects of H22-Fel d 1 in Highly Atopic Subjects. In JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY Vol. 123 (pp. S95). doi:10.1016/j.jaci.2008.12.339

Mohammed, F., Cobbold, M., Zarling, A. L., Salim, M., Barrett-Wilt, G. A., Shabanowitz, J., . . . Willcox, B. E. (2008). Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for the presentation of transformed self. NATURE IMMUNOLOGY, 9(11), 1236-1243. doi:10.1038/ni.1660

Ferguson, A. R., Nichols, L. A., Zarling, A. L., Thompson, E. D., Brinkman, C. C., Hargadon, K. M., . . . Engelhard, V. H. (2008). Strategies and challenges in eliciting immunity to melanoma. IMMUNOLOGICAL REVIEWS, 222, 28-42. doi:10.1111/j.1600-065X.2008.00620.x

Mohammed, F., Cobbold, M., Zarling, A. L., Salim, M., Barrett-Wilt, G. A., Shabanowitz, J., . . . Willcox, B. E. (2008). Phosphorylation-dependent interaction of antigenic peptides with class I MHC: a molecular basis for the presentation of transformed self. In IMMUNOLOGY Vol. 125 (pp. 51).

Depontieu, F., Qian, J., Zarling, A. L., McMiller, T. L., Shabanowitz, J., Hunt, D. F., . . . Topalian, S. L. (2008). Tumor-associated MHC II-restricted phosphopeptides: New targets for immune recognition. In FASEB JOURNAL Vol. 22.

Cobbold, M., Barrett-Wilt, G. A., Polefrome, J. M., Shabanowitz, J., Hunt, D. F., & Engelhard, V. H. (2008). Global assessment of HLA-A2 peptide display: improving epitope prediction. In IMMUNOLOGY Vol. 125 (pp. 76).

Lengagne, R., Graff-Dubois, S., Garcette, M., Renia, L., Kato, M., Guillet, J. -G., . . . Prevost-Blondel, A. (2008). Distinct role for CD8 T cells toward cutaneous tumors and visceral metastases. JOURNAL OF IMMUNOLOGY, 180(1), 130-137. doi:10.4049/jimmunol.180.1.130

Nicholls, S., Piper, K. P., Mohammed, F., Dafforn, T. R., Tenzer, S., Salim, M., . . . Willcox, B. E. (2008). Immunological targeting of the cancer phosphoproteome. In IMMUNOLOGY Vol. 125 (pp. 51-52).

Robila, V., Ostankovitch, M., Altrich-VanLith, M. L., Theos, A. C., Drover, S., Marks, M. S., . . . Engelhard, V. H. (2008). MHC Class II Presentation of gp100 Epitopes in Melanoma Cells Requires the Function of Conventional Endosomes and Is Influenced by Melanosomes. JOURNAL OF IMMUNOLOGY, 181(11), 7843-7852. doi:10.4049/jimmunol.181.11.7843

Brinkman, C. C., Sheasley-O'Neill, S. L., Ferguson, A. R., & Engelhard, V. H. (2008). Activated CD8 T cells redistribute to antigen-free lymph nodes and exhibit effector and memory characteristics. JOURNAL OF IMMUNOLOGY, 181(3), 1814-1824. doi:10.4049/jimmunol.181.3.1814

Cobbold, M., Polefrone, J. M., Qian, J., Mohammed, F., Norris, A., De Santis, A., . . . Engelhard, V. (2008). Immune targeting of the phosphoproteome in hematolymphoid malignancy. In ANNALS OF ONCOLOGY Vol. 19 (pp. 158).

Cobbold, M., Qian, J., Polefrome, J. M., Zarling, A. L., Norris, A., Shabanowitz, J., . . . Engelhard, V. H. (2008). Immunological targeting of the cancer phosphoproteome.. In IMMUNOLOGY Vol. 125 (pp. 51).

Hulse, K. E., Reefer, A. J., Satinover, S. M., Chapman, M. D., Engelhard, V. H., & Woodfolk, J. A. (2008). Targeting fel d 1 to FcγRI:: Single cell analysis reveals a novel variation of the Th2 response in cat-allergic subjects. In JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY Vol. 121 (pp. S145). doi:10.1016/j.jaci.2007.12.1114

Hulse, K. E., Reefer, A. J., Engelhard, V. H., Satinover, S. M., Patrie, J. T., Chapman, M. D., & Woodfolk, J. A. (2008). Targeting Fel d 1 to FcγRI induces a novel variation of the T_H2 response in subjects with cat allergy. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 121(3), 756-762. doi:10.1016/j.jaci.2007.10.016

Hunt, D. F., Henderson, R. A., Shabanowitz, J., Sakaguchi, K., Michel, H., Sevilir, N., . . . Engelhard, V. H. (2007). Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry (Reprinted from Science, vol 255, March 6, 1992). JOURNAL OF IMMUNOLOGY, 179(5), 2669-2671. doi:10.1126/science.1546328

Sheasley-O'Neill, S. L., Brinkman, C. C., Ferguson, A. R., Dispenza, M. C., & Engelhard, V. H. (2007). Dendritic cell immunization route determines integrin expression and lymphoid and nonlymphoid tissue distribution of CD8 T cells. JOURNAL OF IMMUNOLOGY, 178(3), 1512-1522. doi:10.4049/jimmunol.178.3.1512

Nichols, L. A., Chen, Y., Colella, T. A., Bennett, C. L., Clausen, B. E., & Engelhard, V. H. (2007). Deletional self-tolerance to a melanocyte/melanoma antigen derived from tyrosinase is mediated by a radio-resistant cell in peripheral and mesenteric lymph nodes. JOURNAL OF IMMUNOLOGY, 179(2), 993-1003. doi:10.4049/jimmunol.179.2.993

Engelhard, V. H. (2007). The contributions of mass spectrometry to understanding of immune recognition by T lymphocytes. INTERNATIONAL JOURNAL OF MASS SPECTROMETRY, 259(1-3), 32-39. doi:10.1016/j.ijms.2006.08.009

Li, L., Huang, L., Sung, S. -S. J., Lobo, P. I., Brown, M. G., Gregg, R. K., . . . Okusa, M. D. (2007). NKT cell activation mediates neutrophil IFN-γ production and renal ischemia-reperfusion injury. JOURNAL OF IMMUNOLOGY, 178(9), 5899-5911. doi:10.4049/jimmunol.178.9.5899

Cobbold, M., Polefrone, J. M., Qian, J., Mohammed, F., Norris, A., De Santis, A. M., . . . Engelhard, V. H. (2007). Immune targeting of the phosphoproteome in lymphoma and leukemia. In BLOOD Vol. 110 (pp. 91A). doi:10.1182/blood.V110.11.285.285

Hulse, K., Reefer, A. J., Satinover, S. M., Chapman, M. D., Engelhard, V., & Woodfolk, J. A. (2007). Analysis of T cell skewing by a receptor targeted allergen variant reveals selective enhancement of Th1-promoting cytokines at the APC level. In JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY Vol. 119 (pp. S91). doi:10.1016/j.jaci.2006.11.382

Lappas, C. M., Day, Y. -J., Marshall, M. A., Engelhard, V. H., & Linden, J. (2006). Adenosine A_2Areceptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation. In The Journal of Cell Biology (Vol. 175, Iss. 4, pp. i9). Rockefeller University Press. doi:10.1083/jcb1754oia9

Altrich-VanLith, M. L., Ostankovitch, M., Polefrone, J. M., Mosse, C. A., Shabanowitz, J., Hunt, D. F., & Engelhard, V. H. (2006). Processing of a class I-restricted epitope from tyrosinase requires peptide N-glycanase and the cooperative action of endoplasmic reticulum aminopeptidase 1 and cytosolic proteases. JOURNAL OF IMMUNOLOGY, 177(8), 5440-5450. doi:10.4049/jimmunol.177.8.5440

Zarling, A. L., Polefrone, J. M., Evans, A. M., Mikesh, L. M., Shabanowitz, J., Lewis, S. T., . . . Hunt, D. F. (2006). Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 103(40), 14889-14894. doi:10.1073/pnas.0604045103

Graff-Dubois, S., Lengagne, R., Garcette, M., Kato, M., Nakashima, I., Engelhard, V., . . . Prévost-Blondel, A. (2006). CD8T cells do not prevent tumor outgrowth, but delay disease progression in a spontaneous melanoma model. In JOURNAL OF INVESTIGATIVE DERMATOLOGY Vol. 126 (pp. 53).

Brickner, A. G., Evans, A. M., Mito, J. K., Xuereb, S. M., Feng, X., Nishida, T., . . . Warren, E. H. (2006). The PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLL. BLOOD, 107(9), 3779-3786. doi:10.1182/blood-2005-08-3501

Engelhard, V. H., Altrich-Vanlith, M., Ostankovitch, M., & Zarling, A. L. (2006). Post-translational modifications of naturally processed MHC-binding epitopes. CURRENT OPINION IN IMMUNOLOGY, 18(1), 92-97. doi:10.1016/j.coi.2005.11.015

Mullins, D. W., & Engelhard, V. H. (2006). Limited infiltration of exogenous dendritic cells and naive T cells restricts immune responses in peripheral lymph nodes. JOURNAL OF IMMUNOLOGY, 176(8), 4535-4542. doi:10.4049/jimmunol.176.8.4535

Lappas, C. M., Day, Y. -J., Marshall, M. A., Engelhard, V. H., & Linden, J. (2006). Adenosine A_2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation. JOURNAL OF EXPERIMENTAL MEDICINE, 203(12), 2639-2648. doi:10.1084/jem.20061097

Hargadon, K. M., Brinkman, C. C., Sheasley-O'Neill, S. L., Nichols, L. A., Bullock, T. N. J., & Engelhard, V. H. (2006). Incomplete differentiation of antigen-specific CD8 T cells in tumor-draining lymph nodes. JOURNAL OF IMMUNOLOGY, 177(9), 6081-6090. doi:10.4049/jimmunol.177.9.6081

Slingluff, C. L., Engelhard, V. H., & Ferrone, S. (2006). Peptide and dendritic cell vaccines. CLINICAL CANCER RESEARCH, 12(7), 2342S-2345S. doi:10.1158/1078-0432.CCR-05-2541

Slingluff, C. L., Chianese-Bullock, K. A., Bullock, T. N. J., Grosh, W. W., Mullins, D. W., Nichols, L., . . . Engelhard, V. H. (2006). Immunity to melanoma antigens: From self-tolerance to immunotherapy. ADVANCES IN IMMUNOLOGY, VOL 90, 90, 243-295. doi:10.1016/S0065-2776(06)90007-8

Hulse, K., Reefer, A. J., Satinover, S. M., Chapman, M. D., Engelhard, V., & Woodfolk, J. A. (2006). Immunomodulation of T cells by targeting allergen to antigen presenting cells. In JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY Vol. 117 (pp. S177). doi:10.1016/j.jaci.2005.12.707

Hulse, K., Reefer, A. J., Satinover, S., Chapman, M. D., Engelhard, V., & Woodfolk, J. A. (2006). Investigating the effects of receptor-targeted allergen on in vitro T cell responses. In JOURNAL OF IMMUNOLOGY Vol. 176 (pp. S286).

Hopkins, L. M., Polefrone, J. M., Zarling, A. L., Evans, A. M., Shabanowitz, J., Hunt, D. F., & Engelhard, V. H. (2005). Differential expression of HLA-A2 and HLA-B7 phosphorylated peptides on cancer and non-cancer cells: New candidates for immunotherapy. In HUMAN IMMUNOLOGY Vol. 66 (pp. S117).

Ostankovitch, M., Robila, V., & Engelhard, V. H. (2005). Regulated folding of tyrosinase in the endoplasmic reticulum demonstrates that misfolded full-length proteins are efficient substrates for class I processing and presentation. JOURNAL OF IMMUNOLOGY, 174(5), 2544-2551. doi:10.4049/jimmunol.174.5.2544

Kharel, Y., Lee, S., Snyder, A. H., Sheasley-O'Neill, S. L., Morris, M. A., Setiady, Y., . . . Lynch, K. R. (2005). Sphingosine kinase 2 is required for modulation of lymphocyte traffic by FTY720. JOURNAL OF BIOLOGICAL CHEMISTRY, 280(44), 36865-36872. doi:10.1074/jbc.M506293200

Yamshchikov, G. V., Mullins, D. W., Chang, C. C., Ogino, T., Thompson, L., Presley, J., . . . Slingluff, C. L. (2005). Sequential immune escape and shifting of T cell responses in a long-term survivor of melanoma. JOURNAL OF IMMUNOLOGY, 174(11), 6863-6871. doi:10.4049/jimmunol.174.11.6863

Ostankovitch, M., Robila, V., & Engelhard, V. (2004). The folding state of tyrosinase in the endoplasmic reticulum regulates its processing and epitope presentation. In FASEB JOURNAL Vol. 18 (pp. C129).

Zarling, A., Evans, A., Shabanowitz, J., Hunt, D., & Engelhard, V. (2004). Phosphorylated class I MHC associated peptides are differentially displayed by cancer cells. In FASEB JOURNAL Vol. 18 (pp. C101).

Mullins, D., & Engelhard, V. (2004). Immunization maneuvers to circumvent the limited capacity of peripheral lymph nodes for exogenous DC and enhance immunologic control of tumors. In JOURNAL OF IMMUNOTHERAPY Vol. 27 (pp. S28). doi:10.1097/00002371-200411000-00101

Brickner, A. G., Evans, A. M., Mito, J. K., Xuereb, S. M., Feng, X., Hunt, D. F., . . . Warren, E. H. (2004). The immunogenicity of a human lymphoid cell-restricted minor histocompatibility antigen results from differential protein translation.. In BLOOD Vol. 104 (pp. 91A).

Engelhard, V. H. (2004). Creating new peptide antigens by slicing and splicing proteins. NATURE IMMUNOLOGY, 5(2), 128-129. doi:10.1038/ni0204-128

Hogan, K. T., Coppola, M. A., Gatlin, C. L., Thompson, L. W., Shabanowitz, J., Hunt, D. F., . . . Slingluff, C. L. (2004). Identification of novel and widely expressed cancer/testis gene isoforms that elicit spontaneous cytotoxic T-lymphocyte reactivity to melanoma. CANCER RESEARCH, 64(3), 1157-1163. doi:10.1158/0008-5472.CAN-03-2209

Thompson, L. W., Hogan, K. T., Caldwell, J. A., Pierce, R. A., Hendrickson, R. C., Deacon, D. H., . . . Slingluff, C. L. (2004). Preventing the spontaneous modification of an HLA-A2-restricted peptide at an N-terminal glutamine or an internal cysteine residue enhances peptide antigenicity. JOURNAL OF IMMUNOTHERAPY, 27(3), 177-183. doi:10.1097/00002371-200405000-00001

Thompson, L. W., Garbee, C. F., Hibbitts, S., Brinckerhoff, L. H., Pierce, R. A., Chianese-Bullock, K. A., . . . Slingluff, C. L. (2004). Competition among peptides in melanoma vaccines for binding to MHC molecules. JOURNAL OF IMMUNOTHERAPY, 27(6), 425-431. doi:10.1097/00002371-200411000-00002

Slingluff, C. L., Petroni, G. R., Yamshchikov, G. V., Barnd, D. L., Eastham, S., Galavotti, H., . . . Engelhard, V. H. (2003). Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells. JOURNAL OF CLINICAL ONCOLOGY, 21(21), 4016-4026. doi:10.1200/JCO.2003.10.005

Spierings, E., Brickner, A. G., Caldwell, J. A., Zegveld, S., Tatsis, N., Blokland, E., . . . Engelhard, V. H. (2003). The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein. BLOOD, 102(2), 621-629. doi:10.1182/blood-2003-01-0260

Brickner, A. G., Evans, A. M., Mito, J. K., Xuereb, S. M., Feng, X., Hunt, D. F., . . . Warren, E. H. (2003). An alternative transcript of the C22orf18 gene encodes a minor histocompatibility antigen that is selectively expressed in B-lymphoid cells.. In BLOOD Vol. 102 (pp. 947A).

Mullins, D. W., & Engelhard, V. H. (2003). Dendritic cell immunization route determines the location of T cell activation, patterns of memory T cell homing, and anti-tumor efficacy. In FASEB JOURNAL Vol. 17 (pp. C330).

Akatsuka, Y., Warren, E. H., Gooley, T. A., Brickner, A. G., Lin, M. T., Hansen, J. A., . . . Riddell, S. R. (2003). Disparity for a newly identified minor histocompatibility antigen, HA-8, correlates with acute graft-versus-host disease after haematopoietic stem cell transplantation from an HLA-identical sibling. BRITISH JOURNAL OF HAEMATOLOGY, 123(4), 671-675. doi:10.1046/j.1365-2141.2003.04676.x

Zarling, A. L., Luckey, C. J., Mart, J. A., White, F. M., Lehner, P. J., Cresswell, P., . . . Engelhard, V. H. (2003). Tapasin is a facilitator, not an editor, of HLA-B8 peptide binding. In FASEB JOURNAL Vol. 17 (pp. C120).

Zarling, A. L., Luckey, C. J., Marto, J. A., White, F. M., Brame, C. J., Evans, A. M., . . . Engelhard, V. H. (2003). Tapasin is a facilitator, not an editor, of class I MHC peptide binding. JOURNAL OF IMMUNOLOGY, 171(10), 5287-5295. doi:10.4049/jimmunol.171.10.5287

Bullock, T. N. J., Mullins, D. W., & Engelhard, V. H. (2003). Antigen density presented by dendritic cells in vivo differentially affects the number and avidity of primary, memory, and recall CD8⁺ T cells. JOURNAL OF IMMUNOLOGY, 170(4), 1822-1829. doi:10.4049/jimmunol.170.4.1822

Mullins, D. W., Sheasley, S. L., Ream, R. M., Bullock, T. N. J., Fu, Y. X., & Engelhard, V. H. (2003). Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control. JOURNAL OF EXPERIMENTAL MEDICINE, 198(7), 1023-1034. doi:10.1084/jem.20021348

Hogan, K., Coppola, M., Gatlin, C., Thompson, L., Shabanowitz, J., Hunt, D., . . . Slingluff, C. (2003). Identification of a novel cancer/testis antigen recognized by melanoma reactive cytotoxic T lymphocytes. In JOURNAL OF IMMUNOTHERAPY Vol. 26 (pp. S7-S8).

Yamshchikov, G., Thompson, L., Mullins, D., Ferrone, S., Ogino, T., Chang, C. C., . . . Slingluff, C. (2003). Immune escape, immune editing, and immune adaptation in a long-term survivor of metastatic melanoma. In JOURNAL OF IMMUNOTHERAPY Vol. 26 (pp. S45).

Hogan, K. T., Coppola, M. A., Gatlin, C. L., Thompson, L. W., Shabanowitz, J., Hunt, D. F., . . . Ross, M. M. (2003). Identification of a shared epitope recognized by melanoma-specific, HLA-A3-restricted cytotoxic T lymphocytes. IMMUNOLOGY LETTERS, 90(2-3), 131-135. doi:10.1016/j.imlet.2003.08.003

Brickner, A. G., Caldwell, J. A., Spierings, E., Blokland, E., Pierce, R., Mollah, S., . . . Engelhard, V. H. (2002). Identification and initial characterization of the human minor histocompatibility antigen HA-3. In TISSUE ANTIGENS Vol. 59 (pp. 5).

Sheasley, S. L., Mullins, D. W., Ream, R. M., & Engelhard, V. H. (2002). Immunization route with peptide-pulsed dendritic cells impacts the location of primary and memory T cell activation. In FASEB JOURNAL Vol. 16 (pp. A334-A335).

Mullins, D. W., Bullock, T. N. J., Sheasley, S. L., & Engelhard, V. H. (2002). Control of tumor outgrowth by regional immunization with peptide-pulsed dendritic cells depends on epitope density. In FASEB JOURNAL Vol. 16 (pp. A334).

Warren, E. H., Otterud, B. E., Linterman, R. W., Brickner, A. G., Engelhard, V. H., Leppert, M. F., . . . Riddell, S. R. (2002). Feasibility of using genetic linkage analysis to identify the genes encoding T cell-defined minor histocompatibility antigens. In TISSUE ANTIGENS Vol. 59 (pp. 44).

Luckey, C. J., Marto, J. A., White, F., Lippolis, J., Nepom, G. T., Masewicz, S., . . . Engelhard, V. H. (2002). Identifying clinically relevant class I and class II peptides using small-scale immuno-precipitation and novel mass spectrometric techniques.. In CLINICAL IMMUNOLOGY Vol. 103 (pp. S131).

Warren, E. H., Otterud, B. E., Linterman, R. W., Brickner, A. G., Engelhard, V. H., Leppert, M. F., . . . Riddell, S. R. (2002). Feasibility of using genetic linkage analysis to identify the genes encoding T cell-defined minor histocompatibility antigens. TISSUE ANTIGENS, 59(4), 293-303. doi:10.1034/j.1399-0039.2002.590407.x

Vermeulen, C. J., Spierings, E., Brickner, A. G., Engelhard, V. H., & Goulmy, E. (2002). HLA-B7 can present a variety of minor histocompatibility antigens within a single patient. In TISSUE ANTIGENS Vol. 59 (pp. 124).

Le Gal, F. A., Prevost-Blondel, A., Lengagne, R., Bossus, M., Farace, F., Chaboissier, A., . . . Gahéry-Ségard, H. (2002). Lipopeptide-based melanoma cancer vaccine induced a strong MART-27-35-cytotoxic T lymphocyte response in a preclinal study. INTERNATIONAL JOURNAL OF CANCER, 98(2), 221-227. doi:10.1002/ijc.10186

Flyer, D. C., Ramakrishna, V., Miller, C., Myers, H., McDaniel, M., Root, K., . . . White, F. M. (2002). Identification by mass spectrometry of CD8⁺-T-cell Mycobacterium tuberculosis epitopes within the Rv0341 gene product. INFECTION AND IMMUNITY, 70(6), 2926-2932. doi:10.1128/IAI.70.6.2926-2932.2002

Engelhard, V. H., Brickner, A. G., & Zarling, A. L. (2002). Insights into antigen processing gained by direct analysis of the naturally processed class I MHC associated peptide repertoire. MOLECULAR IMMUNOLOGY, 39(3-4), 127-137. doi:10.1016/S0161-5890(02)00096-2

Lippolis, J. D., White, F. M., Marto, J. A., Luckey, C. J., Bullock, T. N. J., Shabanowitz, J., . . . Engelhard, V. H. (2002). Analysis of MHC class II antigen processing by quantitation of peptides that constitute nested sets. JOURNAL OF IMMUNOLOGY, 169(9), 5089-5097. doi:10.4049/jimmunol.169.9.5089

Engelhard, V. H., Bullock, T. N. J., Colella, T. A., Sheasley, S. L., & Mullins, D. W. (2002). Antigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy. IMMUNOLOGICAL REVIEWS, 188, 136-146. doi:10.1034/j.1600-065X.2002.18812.x

Norton, E. J., Diekman, A. B., Westbrook, V. A., Mullins, D. W., Klotz, K. L., Gilmer, L. L., . . . Herr, J. C. (2002). A male genital tract-specific carbohydrate epitope on human CD52: Implications for immunocontraception. TISSUE ANTIGENS, 60(5), 354-364. doi:10.1034/j.1399-0039.2002.600502.x

Mosse, C. A., Hsu, W., & Engelhard, V. H. (2001). Tyrosinase degradation via two pathways during reverse translocation to the cytosol. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 285(2), 313-319. doi:10.1006/bbrc.2001.5153

Arichi, T., Saito, T., Major, M. E., Belyakov, I. M., Shirai, M., Engelhard, V. H., . . . Berzofsky, J. A. (2001). Prophylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model, (Retraction of vol 97, pg 297, 2000). PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 98(10), 5943. doi:10.1073/pnas.101132998

Nepom, G. T., Lippolis, J. D., White, F. M., Masewicz, S., Marto, J. A., Herman, A., . . . Nepom, B. S. (2001). Identification and modulation of a naturally processed T cell epitope from the diabetes-associated autoantigen human glutamic acid decarboxylase 65 (hGAD65). PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 98(4), 1763-1768. doi:10.1073/pnas.98.4.1763

Guimezanes, A., Barrett-Wilt, G. A., Gulden-Thompson, P., Shabanowitz, J., Engelhardt, V. H., Hunt, D. F., & Schmitt-Verhulst, A. M. (2001). Identification of endogenous peptides recognized by in vivo or in vitro generated alloreactive cytotoxic T lymphocytes:: distinct characteristics correlated with CD8 dependence. EUROPEAN JOURNAL OF IMMUNOLOGY, 31(2), 421-432. doi:10.1002/1521-4141(200102)31:23.0.CO;2-4

Guimezanes, A., Barrett-Wilt, G. A., Gulden-Thompson, P., Shabanowitz, J., Engelhardt, V. H., Hunt, D. F., & Schmitt-Verhulst, A. -M. (2001). Identification of endogenous peptides recognized by in vivo or in vitro generated alloreactive cytotoxic T lymphocytes: distinct characteristics correlated with CD8 dependence. European Journal of Immunology, 31(2), 421-432. doi:10.1002/1521-4141(200102)31:23.3.co;2-w

Guimezanes, A., Barrett-Wilt, G. A., Gulden-Thompson, P., Shabanowitz, J., Engelhard, V. H., Hunt, D. F., & Schmitt-Verhulst, A. M. (2001). Identification of endogenous peptides recognized by in vivo or in vitro generated alloreactive cytotoxic T lymphocytes:: distinct characterictics correlated with CD8 dependence (vol 31, pg 421, 2001). EUROPEAN JOURNAL OF IMMUNOLOGY, 31(4), 1298.

Akatsuka, Y., Warren, E. H., Brickner, A. G., Engelhard, V. H., & Riddell, S. R. (2001). Determination of intronic sequences adjacent to an exon using polymerase chain reaction and genomic DNA library constructed by TA cloning. ANALYTICAL BIOCHEMISTRY, 289(2), 289-292. doi:10.1006/abio.2000.4897

Brickner, A. G., Warren, E. H., Caldwell, J. A., Akatsuka, Y., Golovina, T. N., Zarling, A. L., . . . Riddell, S. R. (2001). The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing. JOURNAL OF EXPERIMENTAL MEDICINE, 193(2), 195-205. doi:10.1084/jem.193.2.195

Luckey, C. J., Marto, J. A., Partridge, M., Hall, E., White, F. M., Lippolis, J. D., . . . Engelhard, V. H. (2001). Differences in the expression of human class I MHC alleles and their associated peptides in the presence of proteasome inhibitors. JOURNAL OF IMMUNOLOGY, 167(3), 1212-1221. doi:10.4049/jimmunol.167.3.1212

Pierce, R. A., Field, E. D., Mutis, T., Golovina, T. N., Von Kap-Herr, C., Wilke, M., . . . Engelhard, V. H. (2001). The HA-2 minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein. JOURNAL OF IMMUNOLOGY, 167(6), 3223-3230. doi:10.4049/jimmunol.167.6.3223

Mullins, D. W., Bullock, T. N. J., Colella, T. A., Robila, V. V., & Engelhard, V. H. (2001). Immune responses to the HLA-A*0201-restricted epitopes of tyrosinase and glycoprotein 100 enable control of melanoma outgrowth in HLA-A*0201-transgenic mice. JOURNAL OF IMMUNOLOGY, 167(9), 4853-4860. doi:10.4049/jimmunol.167.9.4853

Bullock, T. N. J., Mullins, D. W., Colella, T. A., & Engelhard, V. H. (2001). Manipulation of avidity to improve effectiveness of adoptively transferred CD8⁺ T cells for melanoma immunotherapy in human MHC class I-transgenic mice. JOURNAL OF IMMUNOLOGY, 167(10), 5824-5831. doi:10.4049/jimmunol.167.10.5824

Slingluff, C. L., Yamshchikov, G., Neese, P., Galavotti, H., Eastham, S., Engelhard, V. H., . . . Ross, W. G. (2001). Phase I trial of a melanoma vaccine with gp100_280-288 peptide and tetanus helper peptide in adjuvant:: Immunologic and clinical outcomes. CLINICAL CANCER RESEARCH, 7(10), 3012-3024.

Yamshchikov, G. V., Barnd, D. L., Eastham, S., Galavotti, H., Patterson, J. W., Deacon, D. H., . . . Slingluff, G. L. (2001). Evaluation of peptide vaccine immunogenicity in draining lymph nodes and peripheral blood of melanoma patients. INTERNATIONAL JOURNAL OF CANCER, 92(5), 703-711. doi:10.1002/1097-0215(20010601)92:53.0.CO;2-5

Akatsuka, Y., Warren, E. H., Brickner, A. G., Lin, M. T., Gooly, T., Martin, P. J., . . . Riddell, S. R. (2000). Effect of disparity in the newly identified minor histocompatibility antigen SKH13 on the development of graft-versus-host disease after marrow transplantation from an HLA-identical sibling.. In BLOOD Vol. 96 (pp. 202A).

Warren, E. H., Caldwell, J. A., Shabanowitz, J., Hunt, D. F., Riddell, S. R., & Engelhard, V. H. (2000). Identification of a new HLA-A*0201-restricted human minor histocompatibility antigen.. In FASEB JOURNAL Vol. 14 (pp. A1070).

Arichi, T., Saito, T., Major, M. E., Belyakov, I. M., Shirai, M., Engelhard, V. H., . . . Berzofsky, J. A. (2000). Prophylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model (Retracted Article. See vol 98, pg 5943, 2001). PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 97(1), 297-302. doi:10.1073/pnas.97.1.297

Pierce, R. A., Field, E. D., den Haan, J. M., Caldwell, J. A., White, F. M., Marto, J. A., . . . Engelhard, V. H. (2000). Identification of the HLA-A*0101 restricted HY minor histocompatibility antigen using a novel mass spectrometric technique. In FASEB JOURNAL Vol. 14 (pp. A1071).

Arichi, T., Major, M. E., Saito, T., Nishioka, M., Engelhard, V. H., Feinstone, S. M., & Berzolsky, J. A. (2000). Application of epitope enhancement to a prophylactic DNA vaccine for hepatitis C virus (HCV) in an HLA-A2.1 transgenic mouse model: Enhanced HCV specific CTL induction and protection from HCV-recombinant vaccinia infection.. In HEPATOLOGY Vol. 32 (pp. 373A).

Crotzer, V. L., Christian, R. E., Brooks, J. M., Shabanowitz, J., Settlage, R. E., Marto, J. A., . . . Engelhard, V. H. (2000). Immunodominance among EBV-derived epitopes restricted by HLA-B27 does not correlate with epitope abundance in EBV-transformed B-lymphoblastoid cell lines. JOURNAL OF IMMUNOLOGY, 164(12), 6120-6129. doi:10.4049/jimmunol.164.12.6120

Zarling, A. L., Ficarro, S. B., White, F. M., Shabanowitz, J., Hunt, D. F., & Engelhard, V. H. (2000). Phosphorylated peptides are naturally processed and presented by major histocompatibility complex class I molecules in vivo. JOURNAL OF EXPERIMENTAL MEDICINE, 192(12), 1755-1762. doi:10.1084/jem.192.12.1755

Bullock, T. N. J., Colella, T. A., & Engelhard, V. H. (2000). The density of peptides displayed by dendritic cells affects immune responses to human tyrosinase and gp100 in HLA-A2 transgenic mice. JOURNAL OF IMMUNOLOGY, 164(5), 2354-2361. doi:10.4049/jimmunol.164.5.2354

Colella, T. A., Bullock, T. N. J., Russell, L. B., Mullins, D. W., Overwijk, W. W., Luckey, C. J., . . . Engelhard, V. H. (2000). Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: Implications for tumor immunotherapy. JOURNAL OF EXPERIMENTAL MEDICINE, 191(7), 1221-1231. doi:10.1084/jem.191.7.1221

Engelhard, V. H., Bullock, T. N. V., Colella, T. A., & Mullins, D. W. (2000). Direct identification of human tumor-associated peptide antigens and a preclinical model to evaluate their use. CANCER JOURNAL, 6, S272-S280.

Lippolis, J. D., Denis-Mize, K. S., Brinckerhoff, L. H., Slingluff, C. L., Galloway, D. R., & Engelhard, V. H. (2000). Pseudomonas exotoxin-mediated delivery of exogenous antigens to MHC class I and class II processing pathways. CELLULAR IMMUNOLOGY, 203(2), 75-83. doi:10.1006/cimm.2000.1685

Slingluff, C. L., Colella, T. A., Thompson, L., Graham, D. D., Skipper, J. C. A., Caldwell, J., . . . Engelhard, V. H. (2000). Melanomas with concordant loss of multiple melanocytic differentiation proteins: immune escape that may be overcome by targeting unique or undefined antigens. CANCER IMMUNOLOGY IMMUNOTHERAPY, 48(12), 661-672. doi:10.1007/s002620050015

Pierce, R. A., Field, E. D., den Haan, J. M. M., Caldwell, J. A., White, F. M., Marto, J. A., . . . Engelhard, V. H. (1999). Cutting edge:: The HLA-A*0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique. JOURNAL OF IMMUNOLOGY, 163(12), 6360-6364.

Wang, W., Gulden, P. H., Pierce, R. A., Shabanowitz, J. A., Man, S. T., Hunt, D. F., & Engelhard, V. H. (1999). A naturally processed peptide presented by HLA-A*0201 is expressed at low abundance and recognized by an alloreactive CD8⁺ cytotoxic T cell with apparent high affinity (vol 158, pg 5797, 1997). JOURNAL OF IMMUNOLOGY, 162(5), 3106.

Kittlesen, D. J., Thompson, L. W., Gulden, P. H., Skipper, J. C. A., Colella, T. A., Shabanowitz, J., . . . Slingluff, C. L. (1999). Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: Implications for tumor vaccine development (vol 160, pg 2099, 1998). In JOURNAL OF IMMUNOLOGY Vol. 162 (pp. 3106).

Arichi, T., Saito, T., Major, M. E., Shirai, M., Engelhard, V. H., Feinstone, S. M., & Berzofsky, J. A. (1999). A DNA vaccine as a prophylaxis for hepatitis C virus (HCV) infection. HCV specific CTL induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model.. In HEPATOLOGY Vol. 30 (pp. 409A).

Skipper, J. C. A., Gulden, P. H., Hendrickson, R. C., Harthun, N., Caldwell, J. A., Shabanowitz, J., . . . Slingluff, C. L. (1999). Mass-spectrometric evaluation of HLA-A*0201-associated peptides identifies dominant naturally processed forms of CTL epitopes from MART-1 and gp100. INTERNATIONAL JOURNAL OF CANCER, 82(5), 669-677. doi:10.1002/(SICI)1097-0215(19990827)82:53.0.CO;2-#

Brinckerhoff, L. H., Kalashnikov, V. V., Thompson, L. W., Yamshchikov, G. V., Pierce, R. A., Galavotti, H. S., . . . Slingluff, C. L. (1999). Terminal modifications inhibit proteolytic degradation of an immunogenic MART-1_27-35 peptide:: Implications for peptide vaccines. INTERNATIONAL JOURNAL OF CANCER, 83(3), 326-334. doi:10.1002/(SICI)1097-0215(19991029)83:33.0.CO;2-X

Mosse, C. A., Meadows, L., Luckey, C. J., Kittlesen, D. J., Huczko, E. L., Slingluff, C. L., . . . Engelhard, V. H. (1998). The class I antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosol. JOURNAL OF EXPERIMENTAL MEDICINE, 187(1), 37-48. doi:10.1084/jem.187.1.37

Sarobe, P., Pendleton, C. D., Akatsuka, T., Lau, D., Engelhard, V. H., Feinstone, S. M., & Berzofsky, J. A. (1998). Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions. JOURNAL OF CLINICAL INVESTIGATION, 102(6), 1239-1248. doi:10.1172/JCI3714

den Haan, J. M. M., Meadows, L. M., Wang, W., Pool, J., Blokland, E., Bishop, T. L., . . . Goulmy, E. (1998). The minor histocompatibility antigen HA-1: A diallelic gene with a single amino acid polymorphism. SCIENCE, 279(5353), 1054-1057. doi:10.1126/science.279.5353.1054

Wang, W., Man, S., Gulden, P. H., Hunt, D. F., & Engelhard, V. H. (1998). Class I-restricted alloreactive cytotoxic T lymphocytes recognize a complex array of specific MHC-associated peptides. JOURNAL OF IMMUNOLOGY, 160(3), 1091-1097.

Luckey, C. J., King, G. M., Marto, J. A., Venketeswaran, S., Maier, B. F., Crotzer, V. L., . . . Engelhard, V. H. (1998). Proteasomes can either generate or destroy MHC class I epitopes: Evidence for nonproteasomal epitope generation in the cytosol. JOURNAL OF IMMUNOLOGY, 161(1), 112-121.

Colella, T. A., Kittlesen, D. J., Luckey, C. J., Thompson, L. W., Slingluff, C. L., & Engelhard, V. H. (1998). The presentation of peptide antigens derived from melanocyte-differentiation proteins by cultured melanocytes: Implications for tumor immunotherapy.. In FASEB JOURNAL Vol. 12 (pp. A289).

Kittlesen, D. J., Thompson, L. W., Gulden, P. H., Skipper, J. C. A., Colella, T. A., Shabanowitz, J. A., . . . Slingluff, C. L. (1998). Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: Implications for tumor vaccine development. JOURNAL OF IMMUNOLOGY, 160(5), 2099-2106.

Hogan, K. T., Eisinger, D. P., Cupp, S. B., Lekstrom, K. J., Deacon, D. D., Shabanowitz, J., . . . Ross, M. M. (1998). The peptide recognized by HLA-A68.2-restricted, squamous cell carcinoma of the lung-specific cytotoxic T lymphocytes is derived from a mutated Elongation Factor 2 gene. CANCER RESEARCH, 58(22), 5144-5150.

den Haan, J. M. M., Wang, W., Meadows, L. R., Blokland, E., Reinhardus, C., Engelhard, V. H., . . . Goulmy, E. (1997). Identification of the human minor histocompatibility antigen HA-1. Immunology Letters, 56, 464. doi:10.1016/s0165-2478(97)88898-0

Loftus, D. J., Chen, Y., Covell, D. G., Engelhard, V. H., & Appella, E. (1997). Differential contact of disparate class I peptide complexes as the basis for epitope cross-recognition by a single T cell receptor. JOURNAL OF IMMUNOLOGY, 158(8), 3651-3658.

Smith, K. D., Huczko, E., Engelhard, V. H., Li, Y. Y., & Lutz, C. T. (1997). Alloreactive cytotoxic T lymphocytes focus on specific major histocompatibility complex-bound peptides. TRANSPLANTATION, 64(2), 351-359. doi:10.1097/00007890-199707270-00030

Dubey, P., Hendrickson, R. C., Meredith, S. C., Siegel, C. T., Shabanowitz, J., Skipper, J. C. A., . . . Schreiber, H. (1997). The immunodominant antigen of an ultraviolet-induced regressor tumor is generated by a somatic point mutation in the DEAD box helicase p68. JOURNAL OF EXPERIMENTAL MEDICINE, 185(4), 695-705. doi:10.1084/jem.185.4.695

Genestier, L., Paillot, R., BonnefoyBerard, N., Meffre, G., Flacher, M., Fevre, D., . . . Revillard, J. P. (1997). Fas-independent apoptosis of activated T cells induced by antibodies to the HLA class I alpha 1 domain. BLOOD, 90(9), 3629-3639. doi:10.1182/blood.V90.9.3629

Meadows, L., Wang, W., denHaan, J. M. M., Blokland, E., Reinhardus, C., Drijfhout, J. W., . . . Engelhard, V. H. (1997). The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. IMMUNITY, 6(3), 273-281. doi:10.1016/S1074-7613(00)80330-1

Williams, N. S., & Engelhard, V. H. (1997). Perforin-dependent cytotoxic activity and lymphokine secretion by CD4(+) T cells are regulated by CD8(+) T cells. JOURNAL OF IMMUNOLOGY, 159(5), 2091-2099.

Wang, W., Gulden, P. H., Pierce, R. A., Shabanowitz, J. A., Man, S. T., Hunt, D. F., & Engelhard, V. H. (1997). A naturally processed peptide presented by HLA-A*0201 is expressed at low abundance and recognized by an alloreactive CD8(+) cytotoxic T cell with apparent high affinity. JOURNAL OF IMMUNOLOGY, 158(12), 5797-5804.

Skipper, J. C., Kittlesen, D. J., Hendrickson, R. C., Deacon, D. D., Harthun, N. L., Wagner, S. N., . . . Slingluff, C. L. (1996). Shared epitopes for HLA-A3-restricted melanoma-reactive human CTL include a naturally processed epitope from Pmel-17/gp100.. Journal of immunology (Baltimore, Md. : 1950), 157(11), 5027-5033.

Slingluff, C. L., Engelhard, V. H., Neese, P., & Cohen, R. (1996). Vaccination of Patients with High-risk Melanoma in the Adjuvant Setting with a Purified gp 100 peptide: Trial Design and Preliminary Findings. In Journal of Immunotherapy Vol. 19 (pp. 457). Ovid Technologies (Wolters Kluwer Health). doi:10.1097/00002371-199611000-00016

Kittlesen, D., Skipper, J., Hendrickson, R., Colella, T., Gulden, P., Hunt, D., . . . Slingluff, C. (1996). Melanoma Patient CTL REcognize HLA-A3 and HLA-A1 Restricted Epitopes Derived From the Melanocyte Differentiation Antigens Pmel-17/gp100 and Tyrosinase. In Journal of Immunotherapy Vol. 19 (pp. 460). Ovid Technologies (Wolters Kluwer Health). doi:10.1097/00002371-199611000-00025

Slingluff, C. L., Graham, D. D., Skipper, J., Kittlesen, D., Deacon, D. H., Colella, T. A., . . . Engelhard, V. H. (1996). Immunologic Escape Variant (IEV) Melanomas with Normal MHC Expression and Antigen Processing Lack Multiple Melanocytic Differentiation Antigens. In Journal of Immunotherapy Vol. 19 (pp. 460). Ovid Technologies (Wolters Kluwer Health). doi:10.1097/00002371-199611000-00027

Huang, A. Y. C., Gulden, P. H., Woods, A. S., Thomas, M. C., Tong, C. D., Wang, W., . . . Jaffee, E. M. (1996). The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 93(18), 9730-9735. doi:10.1073/pnas.93.18.9730

de Haan, J. M. M., Blokland, E., Reinhardus, C., Wang, W., Meadows, L. R., Engelhard, V. H., . . . Goulmy, E. (1996). Identification of human minor histocompatibility antigens. Human Immunology, 47(1-2), 19. doi:10.1016/0198-8859(96)84781-1

Wang, W., Gulden, P. E., Pierce, R. A., Hunt, D. F., & Engelhard, V. H. (1996). A naturally processed peptide presented by HLA-A2.1 is recognized by an alloreactive CD8+ cytotoxic T cell with high affinity. In FASEB JOURNAL Vol. 10 (pp. 2735).

denHaan, J. M. M., Bontrop, R. E., Pool, J., Sherman, N., Blokland, E., Engelhard, V. H., . . . Goulmy, E. (1996). Conservation of minor histocompatibility antigens between human and non-human primates. EUROPEAN JOURNAL OF IMMUNOLOGY, 26(11), 2680-2685. doi:10.1002/eji.1830261120

Williams, N. S., & Engelhard, V. H. (1996). Regulation of the development of perforin-dependent cytotoxicity in CD4(+) T cells by CD8(+) T cells. In FASEB JOURNAL Vol. 10 (pp. 221).

Smith, K. D., Mace, B. E., Valenzuela, A., Vigna, J. L., McCutcheon, J. A., Barbosa, J. A., . . . Lutz, C. T. (1996). Probing HLA-B7 conformational shifts induced by peptide-binding groove mutations and bound peptide with anti-HLA monoclonal antibodies. JOURNAL OF IMMUNOLOGY, 157(6), 2470-2478.

Schumacher, I. K., Newberg, M. H., Jackson, J. D., Hammel, J. M., Rubocki, R. J., Engelhard, V. H., & Fox, I. J. (1996). Use of gene therapy to suppress the antigen-specific immune responses in mice to an HLA antigen. TRANSPLANTATION, 62(6), 831-836. doi:10.1097/00007890-199609270-00022

Huczko, E. L., Rumpel, C. A., Chen, Y., & Engelhard, V. H. (1996). Priming of HLA-A2 restricted responses in transgenic mice. In FASEB JOURNAL Vol. 10 (pp. 2704).

denHaan, J. M. M., Blokland, E., Reinhardus, C., Wang, W., Meadows, L. R., Engelhard, V. H., . . . Goulmy, E. (1996). Identification of human minor histocompatibility antigens. In HUMAN IMMUNOLOGY Vol. 47 (pp. P86).

Williams, N. S., & Engelhard, V. H. (1996). Identification of a population of CD4(+) CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism. JOURNAL OF IMMUNOLOGY, 156(1), 153-159.

Engelhard, V. H. (1996). Direct identification of tumor-associated peptide antigens. SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 18(2), 171-183. doi:10.1007/BF00820664

Newberg, M. H., Smith, D. H., Haertel, S. B., Vining, D. R., Lacy, E., & Engelhard, V. H. (1996). Importance of MHC class I alpha 2 and alpha 3 domains in the recognition of self and non-self MHC molecules. JOURNAL OF IMMUNOLOGY, 156(7), 2473-2480.

Gulden, P. H., Fischer, P., Sherman, N. E., Wang, W., Engelhard, V. H., Shabanowitz, J., . . . Pamer, E. G. (1996). A Listeria monocytogenes pentapeptide is presented to cytolytic T lymphocytes by the H2-M3 MHC class Ib molecule. IMMUNITY, 5(1), 73-79. doi:10.1016/S1074-7613(00)80311-8

Mosse, C. A., Kittlesen, D. J., Skipper, J. C. A., Hendrickson, R., Hunt, D. F., Slingluff, C. L., & Engelhard, V. H. (1996). A tyrosinase epitope is processed after translation into the endoplasmic reticulum. In FASEB JOURNAL Vol. 10 (pp. 2523).

Skipper, J. C. A., Kittlesen, D. J., Hendrickson, R. C., Deacon, D. D., Harthun, N. L., Wagner, S. N., . . . Slingluff, C. L. (1996). Shaved epitopes for HLA-A3-restricted melanoma-reactive human CTL include a naturally processed epitope from Pmel-17/gp100. JOURNAL OF IMMUNOLOGY, 157(11), 5027-5033.

Kittlesen, D., Graham, D., Deacon, D., Colella, T., Huczko, E., Skipper, J., . . . Slingluff, C. (1996). HLA-A2+ melanoma tumor antigen loss variants expressing multiple phenotypes. In FASEB JOURNAL Vol. 10 (pp. 2703).

Skipper, J. C. A., Hendrickson, R. C., Gulden, P. H., Brichard, V., VanPel, A., Chen, Y., . . . Engelhard, V. H. (1996). An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins. JOURNAL OF EXPERIMENTAL MEDICINE, 183(2), 527-534. doi:10.1084/jem.183.2.527

ENGELHARD, V. (1995). HOT PAPERS - TUMOR IMMUNOLOGY - IDENTIFICATION OF A PEPTIDE RECOGNIZED BY 5 MELANOMA-SPECIFIC HUMAN CYTOTOXIC T-CELL LINES - BY COX,A.L., SKIPPER,J., CHEN,Y., HENDERSON,R.A., ENGELHARD,V.H., HUNT,D.F., SLINGLUFF,D.F. - COMMENTS. In SCIENTIST Vol. 9 (pp. 15).

DENHAAN, J. M. M., SHERMAN, N. E., BLOKLAND, E., HUCZKO, E., KONING, F., DRIJFHOUT, J. W., . . . GOULMY, E. (1995). IDENTIFICATION OF A GRAFT-VERSUS-HOST DISEASE-ASSOCIATED HUMAN MINOR HISTOCOMPATIBILITY ANTIGEN. SCIENCE, 268(5216), 1476-1480. doi:10.1126/science.7539551

SIDNEY, J., DELGUERCIO, M. F., SOUTHWOOD, S., ENGELHARD, V. H., APPELLA, E., RAMMENSEE, H. G., . . . SETTE, A. (1995). SEVERAL HLA ALLELES SHARE OVERLAPPING PEPTIDE SPECIFICITIES. JOURNAL OF IMMUNOLOGY, 154(1), 247-259.

ENGELHARD, V. H., MAN, S., NEWBERG, M. H., CROTZER, V. L., LUCKEY, C. J., WILLIAMS, N. S., . . . RIDGE, J. P. (1995). DEFINITION OF A HUMAN T-CELL EPITOPE FROM INFLUENZA-A NONSTRUCTURAL PROTEIN-1 USING HLA-A2.1 TRANSGENIC MICE. In JOURNAL OF CELLULAR BIOCHEMISTRY (pp. 295).

WANG, W., MEADOWS, L. R., DENHAAN, J. M. M., SHERMAN, N. E., CHEN, Y., BLOKLAND, E., . . . ENGELHARD, V. H. (1995). HUMAN H-Y - A MALE-SPECIFIC HISTOCOMPATIBILITY ANTIGEN DERIVED FROM THE SMCY PROTEIN. SCIENCE, 269(5230), 1588-1590. doi:10.1126/science.7667640

SHIRAI, M., ARICHI, T., NISHIOKA, M., NOMURA, T., IKEDA, K., KAWANISHI, K., . . . BERZOFSKY, J. A. (1995). CTL RESPONSES OF HLA-A2.1-TRANSGENIC MICE SPECIFIC FOR HEPATITIS-C VIRAL PEPTIDES PREDICT EPITOPES FOR CTL OF HUMANS CARRYING HLA-A2.1. JOURNAL OF IMMUNOLOGY, 154(6), 2733-2742.

MAN, S., NEWBERG, M. H., CROTZER, V. L., LUCKEY, C. J., WILLIAMS, N. S., CHEN, Y., . . . ENGELHARD, V. H. (1995). DEFINITION OF A HUMAN T-CELL EPITOPE FROM INFLUENZA-A NONSTRUCTURAL PROTEIN-1 USING HLA-A2.1 TRANSGENIC MICE. INTERNATIONAL IMMUNOLOGY, 7(4), 597-605. doi:10.1093/intimm/7.4.597

LOFTUS, D. J., SAKAGUCHI, K., YE, C., SAKAMOTO, H., SETTE, A., ENGELHARD, V. H., & APPELLA, E. (1994). ANALYSIS OF TCR RECOGNITION OF A CLASS-1 PEPTIDE EPITOPE AIDED BY THE USE OF A SYNTHETIC, COMBINATORIAL PEPTIDE LIBRARY. In JOURNAL OF CELLULAR BIOCHEMISTRY (pp. 291).

YE, C., SIDNEY, J., SOUTHWOOD, S., BENJAMIN, D., COX, A. L., SAKAGUCHI, K., . . . ENGELHARD, V. H. (1994). NATURALLY PROCESSED PEPTIDES LONGER THAN 9 AMINO-ACID-RESIDUES BIND TO THE CLASS-I MHC MOLECULE HLA-A2.1 WITH HIGH-AFFINITY AND IN DIFFERENT CONFORMATION. In JOURNAL OF CELLULAR BIOCHEMISTRY (pp. 289).

SMITH, D. M., BLUESTONE, J. A., JEYARAJAH, D. R., NEWBERG, M. H., ENGELHARD, V. H., THISTLETHWAITE, J. R., & WOODLE, E. S. (1994). INHIBITION OF T-CELL ACTIVATION BY A MONOCLONAL-ANTIBODY REACTIVE AGAINST THE ALPHA-3 DOMAIN OF HUMAN MHC CLASS-I MOLECULES. JOURNAL OF IMMUNOLOGY, 153(3), 1054-1067.

LUTZ, C. T., SMITH, K. D., HUCZKO, E. L., & ENGELHARD, V. H. (1994). AN HLA-B7 LEADER PEPTIDE IS RECOGNIZED BY AN HLA-B7-REACTIVE CTL CLONE. In JOURNAL OF CELLULAR BIOCHEMISTRY (pp. 335).

NEWBERG, M. H., SMITH, D., LACY, L., & ENGELHARD, V. H. (1994). SPECIES-SPECIFIC T-CELL RECOGNITION OF BOTH THE ALPHA-2 AND ALPHA-3 DOMAINS OF MHC CLASS-I AND THE ROLE OF CD8. In JOURNAL OF CELLULAR BIOCHEMISTRY (pp. 344).

ENGELHARD, V. H. (1994). STRUCTURE OF PEPTIDES ASSOCIATED WITH CLASS-I AND CLASS-II MHC MOLECULES. ANNUAL REVIEW OF IMMUNOLOGY, 12, 181-207. doi:10.1146/annurev.iy.12.040194.001145

CHEN, Y., SIDNEY, J., SOUTHWOOD, S., COX, A. L., SAKAGUCHI, K., HENDERSON, R. A., . . . ENGELHARD, V. H. (1994). NATURALLY PROCESSED PEPTIDES LONGER THAN 9 AMINO-ACID-RESIDUES BIND TO THE CLASS-I MHC MOLECULE HLA-A2.1 WITH HIGH-AFFINITY AND IN DIFFERENT CONFORMATIONS. JOURNAL OF IMMUNOLOGY, 152(6), 2874-2881.

ENGELHARD, V. H. (1994). STRUCTURE OF PEPTIDES ASSOCIATED WITH MHC CLASS-I MOLECULES. CURRENT OPINION IN IMMUNOLOGY, 6(1), 13-23. doi:10.1016/0952-7915(94)90028-0

BEIER, D. C., COX, J. H., VINING, D. R., CRESSWELL, P., & ENGELHARD, V. H. (1994). ASSOCIATION OF HUMAN CLASS-I MHC ALLELES WITH THE ADENOVIRUS E3/19K PROTEIN. JOURNAL OF IMMUNOLOGY, 152(8), 3862-3872.

ENGELHARD, V. H. (1994). HOW CELLS PROCESS ANTIGENS. SCIENTIFIC AMERICAN, 271(2), 54-61. doi:10.1038/scientificamerican0894-54

MAN, S., RIDGE, J. P., & ENGELHARD, V. H. (1994). DIVERSITY AND DOMINANCE AMONG TCR RECOGNIZING HLA-A2.1(+) INFLUENZA MATRIX PEPTIDE IN HUMAN MHC CLASS-I TRANSGENIC MICE. JOURNAL OF IMMUNOLOGY, 153(10), 4458-4467.

WILLIAMS, N. S., GRAHAM, M. B., BRACIALE, T. J., & ENGELHARD, V. H. (1994). DEVELOPMENT OF CYTOTOXICITY AND PERFORIN GENE-EXPRESSION IN CD4+ AND CD8+ CELLS FROM NAIVE MURINE SPLENOCYTES. In JOURNAL OF CELLULAR BIOCHEMISTRY (pp. 363).

COX, A. L., SKIPPER, J., CHEN, Y., HENDERSON, R. A., DARROW, T. L., SHABANOWITZ, J., . . . SLINGLUFF, C. L. (1994). IDENTIFICATION OF A PEPTIDE RECOGNIZED BY 5 MELANOMA-SPECIFIC HUMAN CYTOTOXIC T-CELL LINES. SCIENCE, 264(5159), 716-719. doi:10.1126/science.7513441

SLINGLUFF, C. L., COX, A. L., STOVER, J. M., MOORE, M. M., HUNT, D. F., & ENGELHARD, V. H. (1994). CYTOTOXIC T-LYMPHOCYTE RESPONSE TO AUTOLOGOUS HUMAN SQUAMOUS-CELL CANCER OF THE LUNG - EPITOPE RECONSTITUTION WITH PEPTIDES EXTRACTED FROM HLA-AW68. CANCER RESEARCH, 54(10), 2731-2737.

SLINGLUFF, C. L., HUNT, D. F., & ENGELHARD, V. H. (1994). DIRECT ANALYSIS OF TUMOR-ASSOCIATED PEPTIDE ANTIGENS. CURRENT OPINION IN IMMUNOLOGY, 6(5), 733-740. doi:10.1016/0952-7915(94)90077-9

Slingluff, C. L., Cox, A. L., Henderson, R. A., Hunt, D. F., & Engelhard, V. H. (1993). Multiple shared HLA-A2.1 associated peptide epitopes for melanoma-specific CTL. In Melanoma Research Vol. 3 (pp. 22). Ovid Technologies (Wolters Kluwer Health). doi:10.1097/00008390-199303000-00074

Engelhard, V. H., Appella, E., Benjamin, D. C., Bodnar, W. M., Cox, A. L., Chen, Y., . . . Hunt, D. F. (1993). Mass Spectrometric Analysis of Peptides Associated with the Human Class I MHC Molecules HLA-A2.1 and HLA-B7 and Identification of Structural Features that Determine Binding. In Chemical Immunology and Allergy (pp. 39-62). KARGER. doi:10.1159/000319180

HUNT, D. F., SHABANOWITZ, J., MICHEL, H., COX, A. L., DICKINSON, T., DAVIS, T., . . . SETTE, A. (1993). SEQUENCE-ANALYSIS OF PEPTIDES PRESENTED TO THE IMMUNE-SYSTEM BY CLASS-I AND CLASS-II MHC MOLECULES. In METHODS IN PROTEIN SEQUENCE ANALYSIS (pp. 127-133).

MAN, S., RIDGE, J. P., & ENGELHARD, V. H. (1993). T-CELL RECEPTOR USAGE OF INFLUENZA SPECIFIC HLA-A2.1 RESTRICTED CYTOTOXIC T-LYMPHOCYTES FROM HLA-A2.1 TRANSGENIC MICE. In JOURNAL OF CELLULAR BIOCHEMISTRY (pp. 52).

ENGELHARD, V. H., HUCZKO, E. L., BODNER, W., BENJAMIN, D., SAKAGUCHI, K., ZHOU, N. Z., . . . HUNT, D. F. (1993). PEPTIDES BOUND TO HLA-B7 DETERMINED BY MASS-SPECTROMETRY. In JOURNAL OF CELLULAR BIOCHEMISTRY (pp. 56).

HENDERSON, R. A., COX, A. L., SAKAGUCHI, K., APPELLA, E., SHABANOWITZ, J., ENGELHARD, V. H., & HUNT, D. F. (1993). IDENTIFICATION OF HLA-A2.1-RESTRICTED T-CELL EPITOPES USING TANDEM MASS-SPECTROMETRY. In JOURNAL OF CELLULAR BIOCHEMISTRY (pp. 104).

BEIER, D. C., COX, J. H., CRESSWELL, P., & ENGELHARD, V. H. (1993). DEFINING THE INTERACTION BETWEEN HLA-A2.1 AND THE ADENOVIRUS E3/19K PROTEIN. In JOURNAL OF CELLULAR BIOCHEMISTRY (pp. 53).

HUCZKO, E. L., BODNER, W., BENJAMIN, D., SAKAGUCHI, K., ZHOU, N. Z., SHABANOWITZ, J., . . . ENGELHARD, V. H. (1993). PEPTIDES BOUND TO HLA-B7 DETERMINED BY MASS-SPECTROMETRY. In JOURNAL OF CELLULAR BIOCHEMISTRY (pp. 105).

Engelhard, V. H., Appella, E., Benjamin, D. C., Bodnar, W. M., Cox, A. L., Chen, Y., . . . Sakaguichi, K. (1993). Mass spectrometric analysis of peptides associated with the human class I MHC molecules HLA-A2.1 and HLA-B7 and identification of structural features that determine binding.. Chemical immunology, 57, 39-62.

HUCZKO, E. L., BODNAR, W. M., BENJAMIN, D., SAKAGUCHI, K., ZHU, N. Z., SHABANOWITZ, J., . . . ENGELHARD, V. H. (1993). CHARACTERISTICS OF ENDOGENOUS PEPTIDES ELUTED FROM THE CLASS-I MHC MOLECULE HLA-B7 DETERMINED BY MASS-SPECTROMETRY AND COMPUTER MODELING. JOURNAL OF IMMUNOLOGY, 151(5), 2572-2587.

HENDERSON, R. A., COX, A. L., SAKAGUCHI, K., APPELLA, E., SHABANOWITZ, J., HUNT, D. F., & ENGELHARD, V. H. (1993). DIRECT IDENTIFICATION OF AN ENDOGENOUS PEPTIDE RECOGNIZED BY MULTIPLE HLA-A2.1-SPECIFIC CYTOTOXIC T-CELLS. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 90(21), 10275-10279. doi:10.1073/pnas.90.21.10275

SLINGLUFF, C. L., COX, A. L., HENDERSON, R. A., HUNT, D. F., & ENGELHARD, V. H. (1993). MULTIPLE SHARED HLA-A2.1 ASSOCIATED PEPTIDE EPITOPES FOR MELANOMA-SPECIFIC CTL. In JOURNAL OF CELLULAR BIOCHEMISTRY (pp. 112).

SLINGLUFF, C. L., COX, A. L., HENDERSON, R. A., HUNT, D. F., & ENGELHARD, V. H. (1993). RECOGNITION OF HUMAN-MELANOMA CELLS BY HLA-A2.1-RESTRICTED CYTOTOXIC T-LYMPHOCYTES IS MEDIATED BY AT LEAST 6 SHARED PEPTIDE EPITOPES. JOURNAL OF IMMUNOLOGY, 150(7), 2955-2963.

Hunt, D. F., Shabanowitz, J., Michel, H., Cox, A. L., Dickinson, T., Davis, T., . . . Sette, A. (1992). Sequence analysis of peptides presented to the immune system by class I and class II MHC molecules. Journal of Protein Chemistry, 11(4), 377-378. doi:10.1007/bf01673734

HUNT, D. F., HENDERSON, R. A., SHABANOWITZ, J., SAKAGUCHI, K., MICHEL, H., SEVILIR, N., . . . ENGELHARD, V. H. (1992). CHARACTERIZATION OF PEPTIDES BOUND TO THE CLASS-I MHC MOLECULE HLA-A2.1 BY MASS-SPECTROMETRY. SCIENCE, 255(5049), 1261-1263. doi:10.1126/science.1546328

MAN, S., SALTER, R. D., & ENGELHARD, V. H. (1992). ROLE OF ENDOGENOUS PEPTIDE IN HUMAN ALLOREACTIVE CYTOTOXIC T-CELL RESPONSES. INTERNATIONAL IMMUNOLOGY, 4(3), 367-375. doi:10.1093/intimm/4.3.367

HENDERSON, R. A., MICHEL, H., SAKAGUCHI, K., SHABANOWITZ, J., APPELLA, E., HUNT, D. F., & ENGELHARD, V. H. (1992). HLA-A2.1-ASSOCIATED PEPTIDES FROM A MUTANT-CELL LINE - A 2ND PATHWAY OF ANTIGEN PRESENTATION. SCIENCE, 255(5049), 1264-1266. doi:10.1126/science.1546329

CRUMPACKER, D. B., ALEXANDER, J., CRESSWELL, P., & ENGELHARD, V. H. (1992). ROLE OF ENDOGENOUS PEPTIDES IN MURINE ALLOGENEIC CYTOTOXIC T-CELL RESPONSES ASSESSED USING TRANSFECTANTS OF THE ANTIGEN-PROCESSING MUTANT 174XCEM.T2. JOURNAL OF IMMUNOLOGY, 148(10), 3004-3011.

BARZAGAGILBERT, E., GRASS, D., LAWRANCE, S. K., PETERSON, P. A., LACY, E., & ENGELHARD, V. H. (1992). SPECIES SPECIFICITY AND AUGMENTATION OF RESPONSES TO CLASS-II MAJOR HISTOCOMPATIBILITY COMPLEX-MOLECULES IN HUMAN CD4 TRANSGENIC MICE. JOURNAL OF EXPERIMENTAL MEDICINE, 175(6), 1707-1715. doi:10.1084/jem.175.6.1707

NEWBERG, M. H., RIDGE, J. P., VINING, D. R., SALTER, R. D., & ENGELHARD, V. H. (1992). SPECIES SPECIFICITY IN THE INTERACTION OF CD8 WITH THE ALPHA-3 DOMAIN OF MHC CLASS-I MOLECULES. JOURNAL OF IMMUNOLOGY, 149(1), 136-142.

BARZAGAGILBERT, E., GRASS, D., LAWRANCE, S., LACY, E., & ENGELHARD, V. H. (1991). T-CELL RESPONSES TO HUMAN CLASS-II MOLECULES IN HUMAN CD4 TRANSGENIC MICE. In FASEB JOURNAL Vol. 5 (pp. A1336).

MAN, S., SALTER, R. D., & ENGELHARD, V. H. (1991). DEPENDENCE OF HLA-A2 SPECIFIC ALLOREACTIVE CTL RESPONSES UPON ENDOGENOUS PEPTIDES. In FASEB JOURNAL Vol. 5 (pp. A1461).

CRUMPACKER, D., ALEXANDER, J., CRESSWELL, P., & ENGELHARD, V. H. (1991). ENDOGENOUS PEPTIDE DEPENDENCE OF MURINE ALLOGENEIC CTL RESPONSES ASSESSED USING TRANSFECTANTS OF THE ANTIGEN PROCESSING MUTANT 174XCEM.T2. In FASEB JOURNAL Vol. 5 (pp. A725).

NEWBERG, M. H., RIDGE, J. P., SALTER, R. D., & ENGELHARD, V. H. (1991). SPECIES SPECIFICITY IN THE INTERACTION OF CD8 WITH THE ALPHA-3 DOMAIN OF MHC CLASS I MOLECULES. In FASEB JOURNAL Vol. 5 (pp. A1378).

HENDERSON, R. A., BARBOSA, J. A., & ENGELHARD, V. H. (1991). ENDOGENOUS PEPTIDE DEPENDENCE OF MURINE HLA-A2.1 SPECIFIC CTL CLONES ASSESSED BY THE ANTIGEN PROCESSING MUTANT 174XCEMT2. In FASEB JOURNAL Vol. 5 (pp. A1683).

ENGELHARD, V. H., LACY, E., & RIDGE, J. P. (1991). INFLUENZA A-SPECIFIC, HLA-A2.1-RESTRICTED CYTOTOXIC LYMPHOCYTES-T FROM HLA-A2.1 TRANSGENIC MICE RECOGNIZE FRAGMENTS OF THE M1-PROTEIN. JOURNAL OF IMMUNOLOGY, 146(4), 1226-1232.

HAVERSTICK, D. M., ENGELHARD, V. H., & GRAY, L. S. (1991). 3 INTRACELLULAR SIGNALS FOR CYTOTOXIC LYMPHOCYTE-T-MEDIATED KILLING - INDEPENDENT ROLES FOR PROTEIN-KINASE-C, CA2+ INFLUX, AND CA2+ RELEASE FROM INTERNAL STORES. JOURNAL OF IMMUNOLOGY, 146(10), 3306-3313.

Engelhard, V. H., Bernhard, E. J., Holterman, M. J., Le, A. -X. T., Henderson, R., Ridge, J. P., . . . Lacy, E. (1990). Cytotoxic T Cell Responses Against Human Class I Molecules in Normal and HLA-A2.1 Transgenic Mice. In Transgenic Mice and Mutants in MHC Research (pp. 179-190). Springer Berlin Heidelberg. doi:10.1007/978-3-642-75442-5_25

Hogan, K. T., Clayberger, C., Shimojo, N., Biddison, W. E., Krensky, A. M., & Engelhard, V. H. (1990). The Role of Amino Acid Position and Side Chain Structure in Serological and CTL-Defined Epitopes on the HLA-A2.1 Molecule. In Transgenic Mice and Mutants in MHC Research (pp. 77-88). Springer Berlin Heidelberg. doi:10.1007/978-3-642-75442-5_12

SPITS, H., PALIARD, X., ENGELHARD, V. H., & DEVRIES, J. E. (1990). CYTOTOXIC ACTIVITY AND LYMPHOKINE PRODUCTION OF T-CELL RECEPTOR (TCR)-ALPHA-BETA+ AND TCR-GAMMA-DELTA+ CYTOTOXIC LYMPHOCYTE-T (CTL) CLONES RECOGNIZING HLA-A2 AND HLA-A2 MUTANTS - RECOGNITION OF TCR-GAMMA-DELTA+ CTL CLONES IS AFFECTED BY MUTATIONS AT POSITION-152 AND POSITION-156. JOURNAL OF IMMUNOLOGY, 144(11), 4156-4162.

Engelhard, V. H., Holterman, M., & Le, A. -X. T. (1989). Weak Stimulation of Murine Cytotoxic T Cells by Human Class I Molecules Maps to the αl + α2 Domains. In Immunobiology of HLA (pp. 140-142). Springer Berlin Heidelberg. doi:10.1007/978-3-662-39946-0_36

Hogan, K. T., Ridge, J. P., Walk, S. F., Engelhard, V. H., & Parham, P. (1989). Mapping of Serologic and CTL-Defined Epitopes on HLA-A2 by Site-Directed Mutagenesis. In Immunobiology of HLA (pp. 101-103). Springer Berlin Heidelberg. doi:10.1007/978-3-662-39946-0_15

SHIMOJO, N., COWAN, E. P., ENGELHARD, V. H., MALOY, W. L., COLIGAN, J. E., & BIDDISON, W. E. (1989). A SINGLE AMINO-ACID SUBSTITUTION IN HLA-A2 CAN ALTER THE SELECTION OF THE CYTO-TOXIC LYMPHOCYTE-T REPERTOIRE THAT RESPONDS TO INFLUENZA-VIRUS MATRIX PEPTIDE 55-73. JOURNAL OF IMMUNOLOGY, 143(2), 558-564.

SCHAIN, D. C., PETRI, W. A., ENGELHARD, V. H., ROCHE, J. K., & RAVDIN, J. I. (1989). IMMUNIZATION WITH ENTAMOEBA-HISTOLYTICA ADHERENCE LECTIN ELICITS AN AMEBICIDAL CELL-MEDIATED IMMUNE-RESPONSE. In CLINICAL RESEARCH Vol. 37 (pp. A439).

LE, A. X. T., BERNHARD, E. J., HOLTERMAN, M. J., STRUB, S., PARHAM, P., LACY, E., & ENGELHARD, V. H. (1989). CYTO-TOXIC T-CELL RESPONSES IN HLA-A2.1 TRANSGENIC MICE - RECOGNITION OF HLA ALLOANTIGENS AND UTILIZATION OF HLA-A2.1 AS A RESTRICTION ELEMENT. JOURNAL OF IMMUNOLOGY, 142(4), 1366-1371.

HOGAN, K. T., CLAYBERGER, C., BERNHARD, E. J., WALK, S. F., RIDGE, J. P., PARHAM, P., . . . ENGELHARD, V. H. (1989). A PANEL OF UNIQUE HLA-A2 MUTANT MOLECULES DEFINE EPITOPES RECOGNIZED BY HLA-A2-SPECIFIC ANTIBODIES AND CYTO-TOXIC LYMPHOCYTES-T. JOURNAL OF IMMUNOLOGY, 142(6), 2097-2104.

GRAY, L. S., HUBER, K. S., GRAY, M. C., HEWLETT, E. L., & ENGELHARD, V. H. (1989). PERTUSSIS TOXIN EFFECTS ON LYMPHOCYTES-T ARE MEDIATED THROUGH CD3 AND NOT BY PERTUSSIS TOXIN CATALYZED MODIFICATION OF A G-PROTEIN. JOURNAL OF IMMUNOLOGY, 142(5), 1631-1638.

NORMENT, A. M., SALTER, R. D., PARHAM, P., ENGELHARD, V. H., & LITTMAN, D. R. (1988). CELL-CELL ADHESION MEDIATED BY CD8 AND MHC CLASS-I MOLECULES. NATURE, 336(6194), 79-81. doi:10.1038/336079a0

HOGAN, K. T., CLAYBERGER, C., BERNHARD, E. J., WALK, S. F., RIDGE, J. P., PARHAM, P., . . . ENGELHARD, V. H. (1988). IDENTIFICATION BY SITE-DIRECTED MUTAGENESIS OF AMINO-ACID RESIDUES CONTRIBUTING TO SEROLOGIC AND CTL-DEFINED EPITOPE DIFFERENCES BETWEEN HLA-A2.1 AND HLA-A2.3. JOURNAL OF IMMUNOLOGY, 141(7), 2519-2525.

HOGAN, K. T., PARHAM, P., & ENGELHARD, V. H. (1988). SITE-DIRECTED MUTAGENESIS OF HLA-A2 IDENTIFIES AMINO-ACID RESIDUES THAT ARE CRITICAL IN THE FORMATION OF SEROLOGIC AND CTL-DEFINED EPITOPES. In FASEB JOURNAL Vol. 2 (pp. A1446).

BERNHARD, E. J., LE, A. T., LACY, E., & ENGELHARD, V. H. (1988). CYTO-TOXIC T-CELLS FROM HLA-A2 EXPRESSING TRANSGENIC MICE RESPOND TO HLA-A2 EXPRESSED ON HUMAN-CELLS. In FASEB JOURNAL Vol. 2 (pp. A1447).

ENGELHARD, V. H., GNARRA, J. R., SULLIVAN, J., MANDELL, G. L., & GRAY, L. S. (1988). EARLY EVENTS IN TARGET-CELL LYSIS BY CYTO-TOXIC T-CELLS. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 532, 303-313. doi:10.1111/j.1749-6632.1988.tb36348.x

Scott, J., Engelhard, V. H., & Benjamin, D. C. (1988). Prevention of diabetes in the BB rat by injection of major histocompatibility complex- (MHC-) compatible bone marrow cells.. Advances in experimental medicine and biology, 246, 387-395. doi:10.1007/978-1-4684-5616-5_47

HOGAN, K. T., SHIMOJO, N., WALK, S. F., ENGELHARD, V. H., MALOY, W. L., COLIGAN, J. E., & BIDDISON, W. E. (1988). MUTATIONS IN THE ALPHA-2 HELIX OF HLA-A2 AFFECT PRESENTATION BUT DO NOT INHIBIT BINDING OF INFLUENZA-VIRUS MATRIX PEPTIDE. JOURNAL OF EXPERIMENTAL MEDICINE, 168(2), 725-736. doi:10.1084/jem.168.2.725

BERNHARD, E. J., LE, A. X. T., BARBOSA, J. A., LACY, E., & ENGELHARD, V. H. (1988). CYTO-TOXIC LYMPHOCYTES-T FROM HLA-A2 TRANSGENIC MICE SPECIFIC FOR HLA-A2 EXPRESSED ON HUMAN-CELLS. JOURNAL OF EXPERIMENTAL MEDICINE, 168(3), 1157-1162. doi:10.1084/jem.168.3.1157

GRAY, L. S., GNARRA, J. R., SULLIVAN, J. A., MANDELL, G. L., & ENGELHARD, V. H. (1988). SPATIAL AND TEMPORAL CHARACTERISTICS OF THE INCREASE IN INTRACELLULAR CA2+ INDUCED IN CYTO-TOXIC LYMPHOCYTES-T BY CELLULAR ANTIGEN. JOURNAL OF IMMUNOLOGY, 141(7), 2424-2430.

ENGELHARD, V. H., LE, A. X. T., & HOLTERMAN, M. J. (1988). SPECIES-SPECIFIC STRUCTURAL DIFFERENCES IN THE ALPHA-1 + ALPHA-2 DOMAINS DETERMINE THE FREQUENCY OF MURINE CYTO-TOXIC T-CELL PRECURSORS STIMULATED BY HUMAN AND MURINE CLASS-I MOLECULES. JOURNAL OF IMMUNOLOGY, 141(6), 1835-1839.

HOGAN, K. T., CLAYBERGER, C., LE, A. T., WALK, S. F., RIDGE, J. P., PARHAM, P., . . . ENGELHARD, V. H. (1988). CYTO-TOXIC LYMPHOCYTE-T-DEFINED EPITOPE DIFFERENCES BETWEEN HLA-A2.1 AND HLA-A2.2 MAP TO 2 DISTINCT REGIONS OF THE MOLECULE. JOURNAL OF IMMUNOLOGY, 141(11), 4005-4011.

GRAY, L. S., GNARRA, J., HEWLETT, E. L., & ENGELHARD, V. H. (1988). INCREASED INTRACELLULAR CYCLIC ADENOSINE-MONOPHOSPHATE INHIBITS LYMPHOCYTE-T MEDIATED CYTOLYSIS BY 2 DISTINCT MECHANISMS. JOURNAL OF EXPERIMENTAL MEDICINE, 167(6), 1963-1968. doi:10.1084/jem.167.6.1963

Scott, J., Benjamin, D. C., Herr, J. C., & Engelhard, V. H. (1988). Sites of the defects leading to autoimmunity in the spontaneously diabetic BB rat.. Advances in experimental medicine and biology, 246, 53-62. doi:10.1007/978-1-4684-5616-5_7

BERNHARD, E., LE, A. T., YANNELLI, J., HOLTERMAN, M., PARHAM, P., & ENGELHARD, V. (1987). THE ABILITY OF CYTOTOXIC T-CELLS TO RECOGNIZE HLA-A2.1 OR HLA-B7 ANTIGENS EXPRESSED ON MURINE TARGETS CORRELATES WITH RECOGNITION OF PARTICULAR EPITOPES. In FEDERATION PROCEEDINGS Vol. 46 (pp. 1049).

GRAY, L. S., GNARRA, J. R., & ENGELHARD, V. H. (1987). DEMONSTRATION OF A CALCIUM INFLUX IN CYTOLYTIC LYMPHOCYTES-T IN RESPONSE TO TARGET-CELL BINDING. JOURNAL OF IMMUNOLOGY, 138(1), 63-69.

HOGAN, K. T., HOLTERMAN, M. J., WALK, S. F., LE, A. T., & ENGELHARD, V. H. (1987). DETERMINATION OF HLA-A2 STRUCTURE-FUNCTION-RELATIONSHIPS BY SITE DIRECTED MUTAGENESIS. In FEDERATION PROCEEDINGS Vol. 46 (pp. 1496).

GRAY, L. S., GNARRA, J. R., RUSSELL, J. H., & ENGELHARD, V. H. (1987). THE ROLE OF K+ IN THE REGULATION OF THE INCREASE IN INTRACELLULAR CA-2+ MEDIATED BY THE LYMPHOCYTE-T ANTIGEN RECEPTOR. CELL, 50(1), 119-127. doi:10.1016/0092-8674(87)90668-4

SCOTT, J., ENGELHARD, V. H., & BENJAMIN, D. C. (1987). BONE-MARROW IRRADIATION CHIMERAS IN THE BB RAT - EVIDENCE SUGGESTING 2 DEFECTS LEADING TO DIABETES AND LYMPHOPOENIA. DIABETOLOGIA, 30(10), 774-781.

BERNHARD, E. J., LE, A. X. T., YANNELLI, J. R., HOLTERMAN, M. J., HOGAN, K. T., PARHAM, P., & ENGELHARD, V. H. (1987). THE ABILITY OF CYTOTOXIC T-CELLS TO RECOGNIZE HLA-A2.1 OR HLA-B7 ANTIGENS EXPRESSED ON MURINE CELLS CORRELATES WITH THEIR EPITOPE SPECIFICITY. JOURNAL OF IMMUNOLOGY, 139(11), 3614-3621.

SCOTT, J., ENGELHARD, V. H., SCOTT, C. A., HERR, J. C., & BENJAMIN, D. C. (1987). NEONATAL TRANSPLANTATION OF MHC-COMPATIBLE THYMUSES INTO DIABETES-PRONE BB RATS. In DIABETOLOGIA Vol. 30 (pp. A580).

HOLTERMAN, M. J., & ENGELHARD, V. H. (1986). HLA ANTIGENS EXPRESSED ON MURINE CELLS ARE PREFERENTIALLY RECOGNIZED BY MURINE CYTOTOXIC-T CELLS IN THE CONTEXT OF THE H-2 MAJOR HISTOCOMPATIBILITY COMPLEX. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 83(24), 9699-9703. doi:10.1073/pnas.83.24.9699

YANNELLI, J., TEWKSBURY, S., THURMAN, G., OLDHAM, R., ENGELHARD, V., SULLIVAN, J., & MANDELL, G. (1986). MORPHOLOGICAL ANALYSIS OF CYTOTOXIC LYMPHOCYTE-TARGET CELL-INTERACTIONS. In PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH Vol. 27 (pp. 360).

GNARRA, J. R., & ENGELHARD, V. H. (1986). NONCYTOTOXIC CELL-LINES DERIVED FROM CTL CLONES CONTINUE TO EXPRESS THE ANTIGEN RECEPTOR. In FEDERATION PROCEEDINGS Vol. 45 (pp. 384).

GNARRA, J. R., & ENGELHARD, V. H. (1986). DERIVATION OF CYTOTOXIC T-CELL LINES THAT EXPRESS T-CELL RECEPTOR BUT EXHIBIT REVERSIBLE LOSS OF STABLE ANTIGEN-BINDING. JOURNAL OF IMMUNOLOGY, 137(10), 3057-3064.

SCOTT, J., ENGELHARD, V. H., CURNOW, R. T., & BENJAMIN, D. C. (1986). PREVENTION OF DIABETES IN BB RATS .1. EVIDENCE SUGGESTING A REQUIREMENT FOR MATURE T-CELLS IN BONE-MARROW INOCULUM OF NEONATALLY INJECTED RATS. DIABETES, 35(9), 1034-1040. doi:10.2337/diabetes.35.9.1034

YANNELLI, J. R., SULLIVAN, J. A., MANDELL, G. L., & ENGELHARD, V. H. (1986). REORIENTATION AND FUSION OF CYTOTOXIC LYMPHOCYTE-T GRANULES AFTER INTERACTION WITH TARGET-CELLS AS DETERMINED BY HIGH-RESOLUTION CINEMICROGRAPHY. JOURNAL OF IMMUNOLOGY, 136(2), 377-382.

YANNELLI, J. R., TEWKSBURY, S. G., THURMAN, G. B., OLDHAM, R. K., ENGELHARD, V. H., SULLIVAN, J. A., & MANDELL, G. L. (1986). MORPHOLOGICAL ANALYSIS OF CYTOTOXIC LYMPHOCYTE-TARGET CELL-INTERACTIONS. In JOURNAL OF CELLULAR BIOCHEMISTRY (pp. 95).

YANNELLI, J. R., MOORE, L. C., & ENGELHARD, V. H. (1985). MULTIPLE EPITOPES ON HUMAN AND MURINE CELLS EXPRESSING HLA-B7 AS DEFINED BY SPECIFIC MURINE CYTO-TOXIC T-CELL CLONES. JOURNAL OF IMMUNOLOGY, 135(2), 900-905.

ENGELHARD, V. H., YANNELLI, J. R., EVANS, G. A., WALK, S. F., & HOLTERMAN, M. J. (1985). CONSTRUCTION OF NOVEL CLASS-I HISTOCOMPATIBILITY ANTIGENS BY INTERSPECIES EXON SHUFFLING. JOURNAL OF IMMUNOLOGY, 134(6), 4218-4225.

ENGELHARD, V. H., POWERS, G. A., MOORE, L. C., HOLTERMAN, M. J., & CORREAFREIRE, M. C. (1984). CYTO-TOXIC LYMPHOCYTE-T RECOGNITION OF HLA-A/B ANTIGENS INTRODUCED INTO EL4-CELLS BY CELL-LIPOSOME FUSION. JOURNAL OF IMMUNOLOGY, 132(1), 76-80.

CORREAFREIRE, M. C., POWERS, G. A., & ENGELHARD, V. H. (1984). INTRODUCTION OF HLA-A/B ANTIGENS INTO LYMPHOID-CELL MEMBRANES BY CELL-LIPOSOME FUSION. JOURNAL OF IMMUNOLOGY, 132(1), 69-75.

HERMAN, A., WEISSMAN, S., PARHAM, P., & ENGELHARD, V. H. (1983). HLA-SPECIFIC MONOCLONAL MURINE CTL RECOGNIZE L-CELLS EXPRESSING HLA-B7 AFTER DNA-MEDIATED GENE-TRANSFER. In FEDERATION PROCEEDINGS Vol. 42 (pp. 1372).

YANNELLI, J. R., BENJAMIN, C., PARHAM, P., & ENGELHARD, V. H. (1983). XENOGENEIC ANTI-HLA-A2 CTL CLONES RECOGNIZE DIFFERENT ANTIGENIC DETERMINANTS ON THE A2 MOLECULE. In FEDERATION PROCEEDINGS Vol. 42 (pp. 1373).

HERMAN, A., PARHAM, P., WEISSMAN, S. M., & ENGELHARD, V. H. (1983). RECOGNITION BY XENOGENEIC CYTO-TOXIC LYMPHOCYTES-T OF CELLS EXPRESSING HLA-A2 OR HLA-B7 AFTER DNA-MEDIATED GENE-TRANSFER. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 80(16), 5056-5060. doi:10.1073/pnas.80.16.5056

ENGELHARD, V. H., & BENJAMIN, C. (1983). XENOGENEIC CYTO-TOXIC T-CELL CLONES RECOGNIZE ALLOANTIGENIC DETERMINANTS ON HLA-A2. IMMUNOGENETICS, 18(5), 461-473. doi:10.1007/BF00364388

ENGELHARD, V. H., & BENJAMIN, C. (1982). ISOLATION AND CHARACTERIZATION OF MONOCLONAL MOUSE CYTO-TOXIC LYMPHOCYTE-T WITH SPECIFICITY FOR HLA-A,B OR HLA-DR ALLOANTIGENS. JOURNAL OF IMMUNOLOGY, 129(6), 2621-2629.

CORREAFRIERE, M. C., & ENGELHARD, V. H. (1982). INTRODUCTION OF HUMAN HISTOCOMPATIBILITY ANTIGENS INTO MOUSE LYMPHOID-CELL MEMBRANES BY CELL-LIPOSOME FUSION. In BIOPHYSICAL JOURNAL Vol. 37 (pp. A28).

CORREAFRIERE, M. C., & ENGELHARD, V. H. (1982). INTRODUCTION OF HLA-A, B-ANTIGENS INTO LYMPHOBLASTOID CELL-MEMBRANES BY CELL-LIPOSOME FUSION - RECOGNITION BY ANTIBODY AND CYTO-TOXIC T-CELLS. In FEDERATION PROCEEDINGS Vol. 41 (pp. 604).

ENGELHARD, V. H., & BENJAMIN, C. (1982). MONOCLONAL MOUSE CTL SPECIFIC FOR HLA-A, HLA-B AND HLA-DR ANTIGENS. In FEDERATION PROCEEDINGS Vol. 41 (pp. 431).

Strominger, J. L., Engelhard, V. H., Guild, B. C., Kostyk, T. G., Lancet, D., Lopez de Castro, J. A., . . . Pober, J. S. (1981). Complete Primary Structure of Human Histocompatibility Antigen HLA-B7. In Current Trends in Histocompatibility (pp. 479-493). Springer US. doi:10.1007/978-1-4684-3758-4_20

Reiss, C. S., Hemler, M. E., Englehard, V. H., Mier, J. W., Strominger, J. L., & Burakoff, S. J. (1980). Development and characterization of allospecific long-term human cytolytic T-cell lines.. Proceedings of the National Academy of Sciences of the United States of America, 77(9), 5432-5436. doi:10.1073/pnas.77.9.5432

Strominger, J. L., Engelhard, V. H., Guild, B. C., Kostyk, T. G., Lancet, D., Lopez de Castro, J. A., . . . Pober, J. S. (1980). Complete primary structure of human histocompatibility antigen HLA-B7: evolutionary and functional implications.. Current topics in developmental biology, 14(Pt 2), 97-113. doi:10.1016/s0070-2153(08)60190-8

ENGELHARD, V. H., KAUFMAN, J. F., STROMINGER, J. L., & BURAKOFF, S. J. (1980). SPECIFICITY OF MOUSE CYTO-TOXIC LYMPHOCYTE-T STIMULATED WITH EITHER HLA-A AND HLA-B OR HLA-DR ANTIGENS RECONSTITUTED INTO PHOSPHOLIPID-VESICLES. JOURNAL OF EXPERIMENTAL MEDICINE, 152(2), S54-S64.

BURAKOFF, S. J., ENGELHARD, V. H., KAUFMAN, J., & STROMINGER, J. L. (1980). INDUCTION OF SECONDARY CYTO-TOXIC LYMPHOCYTES-T BY LIPOSOMES CONTAINING HLA-DR ANTIGENS. NATURE, 283(5746), 495-497. doi:10.1038/283495a0

ENGELHARD, V. H., BURAKOFF, S., & STROMINGER, J. L. (1979). STIMULATION OF SECONDARY MOUSE CYTOTOXIC T-CELLS WITH HLA-A AND HLA-B ANTIGENS IN PHOSPHOLIPID-VESICLES. In JOURNAL OF SUPRAMOLECULAR STRUCTURE (pp. 260).

WESTCOTT, K. R., ENGELHARD, V. H., & STORM, D. R. (1979). PRODUCTION OF CYCLIC-AMP FROM EXTRACELLULAR ATP BY INTACT LM-CELLS. BIOCHIMICA ET BIOPHYSICA ACTA, 583(1), 47-54. doi:10.1016/0304-4165(79)90308-8

ENGELHARD, V. H., STROMINGER, J. L., MESCHER, M., & BURAKOFF, S. (1978). INDUCTION OF SECONDARY CYTOTOXIC LYMPHOCYTES-T BY PURIFIED HLA-A AND HLA-B ANTIGENS RECONSTITUTED INTO PHOSPHOLIPID VESICLES. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 75(11), 5688-5691. doi:10.1073/pnas.75.11.5688

ENGELHARD, V. H., STORM, D. R., & GLASER, M. (1978). NEGATIVE COOPERATIVITY EXHIBITED BY PROSTAGLANDIN-E1 STIMULATED ADENYLATE-CYCLASE IN LM-CELLS. BIOCHEMISTRY, 17(24), 5304-5308. doi:10.1021/bi00617a034

ENGELHARD, V. H., GUILD, B. C., HELENIUS, A., TERHORST, C., & STROMINGER, J. L. (1978). RECONSTITUTION OF PURIFIED DETERGENT-SOLUBLE HLA-A AND HLA-B ANTIGENS INTO PHOSPHOLIPID VESICLES. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 75(7), 3230-3234. doi:10.1073/pnas.75.7.3230

ENGELHARD, V. H. (1978). RECONSTITUTION OF PURIFIED HUMAN HISTOCOMPATIBILITY ANTIGENS INTO MODEL MEMBRANES. In FEDERATION PROCEEDINGS Vol. 37 (pp. 1468).

ENGELHARD, V. H., GLASER, M., & STORM, D. R. (1978). EFFECT OF MEMBRANE PHOSPHOLIPID COMPOSITIONAL CHANGES ON ADENYLATE-CYCLASE IN LM CELLS. BIOCHEMISTRY, 17(16), 3191-3200. doi:10.1021/bi00609a004

ENGELHARD, V. H., ESKO, J. D., STORM, D. R., & GLASER, M. (1976). MODIFICATION OF ADENYLATE-CYCLASE ACTIVITY IN LM CELLS BY MANIPULATION OF MEMBRANE PHOSPHOLIPID COMPOSITION INVIVO. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 73(12), 4482-4486. doi:10.1073/pnas.73.12.4482

ENGELHARD, V. H., PLUT, D. A., & STORM, D. R. (1976). SUBCELLULAR LOCATION OF ADENYLATE-CYCLASE IN RAT CARDIAC-MUSCLE. BIOCHIMICA ET BIOPHYSICA ACTA, 451(1), 48-61. doi:10.1016/0304-4165(76)90256-7

ENGELHARD, V. H., ESKO, J. D., STORM, D. R., & GLASER, M. (1976). EFFECT OF CHANGES IN MEMBRANE LIPID-COMPOSITION ON ADENYLATE-CYCLASE OF MOUSE LM CELLS. In FEDERATION PROCEEDINGS Vol. 35 (pp. 1532).